Florian Holsboer

Q: What Schools Are Affiliated With Florian Holsboer

Florian Holsboer is affiliated with the following schools: University of Freiburg, ETH Zurich, Ludwig Maximilian University of Munich, University of Buenos Aires, University of Zurich

Florian Holsboer's AcademicInfluence.com Rankings

Florian Holsboer

Chemistry

#655

World Rank

#1115

Historical Rank

Organic Chemistry

#60

World Rank

#89

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Florian Holsboer's Degrees

PhD Chemistry University of Zurich
Bachelors Chemistry University of Zurich

Why Is Florian Holsboer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Florian Holsboer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Stress and the brain: from adaptation to disease (2005) (4108)
The Corticosteroid Receptor Hypothesis of Depression (2000) (2112)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (2013) (2011)
Differential signal transduction by five splice variants of the PACAP receptor (1993) (1208)
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions (2012) (1178)
Dynamic DNA methylation programs persistent adverse effects of early-life stress (2009) (1151)
A mega-analysis of genome-wide association studies for major depressive disorder (2013) (979)
Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 (1998) (928)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment (2004) (908)
Antidepressants and hypothalamic-pituitary-adrenocortical regulation. (1996) (885)
Neuroprotection against oxidative stress by estrogens: structure-activity relationship. (1997) (770)
Common genetic variants influence human subcortical brain structures (2015) (731)
Genome-wide, large-scale production of mutant mice by ENU mutagenesis (2000) (696)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. (2000) (681)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) (676)
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. (1994) (669)
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions (2007) (657)
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives (1999) (648)
17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. (1995) (637)
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. (1999) (626)
Identification of common variants associated with human hippocampal and intracranial volumes (2012) (617)
Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. (2001) (607)
FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells* (2005) (555)
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study (2000) (543)
Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation (2016) (525)
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo (2000) (509)
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. (2002) (503)
Psychoneuroendocrinology (1979) (458)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress (2003) (444)
Effects of antidepressant treatment on neuroactive steroids in major depression. (1998) (440)
Genomewide Association for Major Depressive Disorder: A possible role for the presynaptic protein Piccolo (2008) (410)
Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? (1995) (402)
Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. (1995) (389)
Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. (1984) (366)
Stress hormone regulation: biological role and translation into therapy. (2010) (366)
Development of the brain's default mode network from wakefulness to slow wave sleep. (2011) (363)
Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. (2001) (363)
Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. (2008) (360)
Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. (1993) (360)
The genetic architecture of the human cerebral cortex (2018) (355)
Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons (1998) (352)
Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression (2008) (341)
Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker? (2007) (341)
V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats (1995) (330)
Corticotropin-releasing hormone receptor subtypes and emotion (1999) (328)
Cellular Localization of Interleukin 6 mRNA and Interleukin 6 Receptor mRNA in Rat Brain (1993) (320)
Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression (2006) (319)
Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour (1998) (315)
RSUME, a Small RWD-Containing Protein, Enhances SUMO Conjugation and Stabilizes HIF-1α during Hypoxia (2007) (314)
Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice (2007) (313)
Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections (2010) (309)
Evidence for a Relationship Between Genetic Variants at the Brain-Derived Neurotrophic Factor (BDNF) Locus and Major Depression (2005) (305)
Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls (2008) (303)
Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. (1982) (300)
Progesterone receptor-mediated effects of neuroactive steroids (1993) (298)
The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus (1994) (297)
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. (2009) (297)
Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS (1994) (294)
Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. (1993) (293)
Gene expression and function of interleukin I, interleukin 6 and tumor necrosis factor in the brain (1994) (293)
Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1 (2011) (291)
Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system (2002) (288)
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. (2001) (288)
Gene Expression Patterns Associated with Posttraumatic Stress Disorder Following Exposure to the World Trade Center Attacks (2009) (280)
Subtle shifts in the ratio between pro‐ and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate (2000) (280)
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. (2002) (279)
The combined dexamethasone/CRH test as a potential surrogate marker in depression (2005) (274)
Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts (2010) (273)
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. (1996) (273)
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome (2008) (269)
The Neurosteroid Tetrahydroprogesterone Attenuates the Endocrine Response to Stress and Exerts Glucocorticoid-like Effects on Vasopressin Gene Transcription in the Rat Hypothalamus (1996) (268)
Stress responsive neurohormones in depression and anxiety. (2003) (262)
Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin (2004) (261)
Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety (2005) (260)
Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. (1988) (252)
Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. (2011) (252)
Genome-wide association study of major recurrent depression in the U.K. population. (2010) (251)
SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection (2019) (250)
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus (2001) (249)
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. (2009) (247)
Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. (1999) (245)
Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender (1994) (244)
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects (2009) (242)
Release of Vasopressin within the Rat Paraventricular Nucleus in Response to Emotional Stress: A Novel Mechanism of Regulating Adrenocorticotropic Hormone Secretion? (1996) (241)
Novel genetic loci associated with hippocampal volume (2017) (238)
FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior (2011) (236)
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. (2006) (236)
Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study (1995) (233)
Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats (1995) (231)
Brain activation and hypothalamic functional connectivity during human non-rapid eye movement sleep: an EEG/fMRI study. (2006) (231)
The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. (2000) (225)
Enhanced and Delayed Stress-Induced Alcohol Drinking in Mice Lacking Functional CRH1 Receptors (2002) (219)
Penetration of Amitriptyline, but Not of Fluoxetine, into Brain is Enhanced in Mice with Blood-Brain Barrier Deficiency Due to Mdr1a P-Glycoprotein Gene Disruption (2000) (219)
Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. (2013) (219)
Corticosteroid receptor function is decreased in depressed patients. (1997) (217)
Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. (1992) (216)
Hormonal Response Pattern in the Combined DEX-CRH Test Is Stable over Time in Subjects at High Familial Risk for Affective Disorders (1998) (215)
The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression (2009) (211)
Psychological Stress Increases Hippocampal Mineralocorticoid Receptor Levels: Involvement of Corticotropin-Releasing Hormone (2001) (210)
Cerebrospinal fluid concentrations of corticotropin‐releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment (1998) (209)
Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. (1997) (207)
Neural correlates of dream lucidity obtained from contrasting lucid versus non-lucid REM sleep: a combined EEG/fMRI case study. (2012) (206)
Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2015) (206)
Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression Implications for pathophysiology of DST nonsuppression (1987) (205)
Penetration of Endogenous Steroid Hormones Corticosterone, Cortisol, Aldosterone and Progesterone into the Brain is Enhanced in Mice Deficient for Both mdr1a and mdr1b P‐Glycoproteins (2002) (205)
Functional microstates within human REM sleep: first evidence from fMRI of a thalamocortical network specific for phasic REM periods (2007) (203)
Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? (2001) (199)
High Constitutive NF-κB Activity Mediates Resistance to Oxidative Stress in Neuronal Cells (1998) (198)
Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders (2001) (196)
Dose-dependent effects of endotoxin on human sleep. (2000) (195)
Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation (2005) (193)
Novel genetic loci underlying human intracranial volume identified through genome-wide association (2016) (192)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption (2003) (192)
Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. (1993) (189)
The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress (2012) (189)
Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. (1999) (189)
Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence (2007) (188)
Altered Processing of Acoustic Stimuli during Sleep: Reduced Auditory Activation and Visual Deactivation Detected by a Combined fMRI/EEG Study (2002) (188)
Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery (1999) (188)
Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD (2010) (187)
Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. (1994) (183)
Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder (2006) (183)
Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats (1995) (183)
Long‐Term Antidepressant Treatment Reduces Behavioural Deficits in Transgenic Mice with Impaired Glucocorticoid Receptor Function (1995) (180)
Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I (1995) (180)
Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. (2011) (179)
Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) (178)
Functional MRI during sleep: BOLD signal decreases and their electrophysiological correlates (2004) (177)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment (2010) (177)
Behavioral, Physiological, and Neuroendocrine Stress Responses and Differential Sensitivity to Diazepam in Two Wistar Rat Lines Selectively Bred for High- and Low-Anxiety–Related Behavior (1998) (176)
Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: Implications for stress-related disorders (2008) (176)
Exacerbation of Apoptosis in the Dentate Gyrus of the Aged Rat by Dexamethasone and the Protective Role of Corticosterone (1996) (176)
Overweight and Obesity Affect Treatment Response in Major Depression (2007) (174)
How can we realize the promise of personalized antidepressant medicines? (2008) (174)
Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. (1996) (173)
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? (2012) (172)
Mice selected for high versus low stress reactivity: A new animal model for affective disorders (2008) (172)
Sleep Spindles and Hippocampal Functional Connectivity in Human NREM Sleep (2011) (171)
The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. (1992) (170)
Long-Term Intracerebroventricular Infusion of Corticotropin-Releasing Hormone Alters Neuroendocrine, Neurochemical, Autonomic, Behavioral, and Cytokine Responses to a Systemic Inflammatory Challenge (1997) (169)
Depression, comorbidities and the TNF-α system (2008) (168)
Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats: Implications for Pathogenesis of Affective Disorders (2002) (167)
Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain (2000) (165)
Neuropeptide S receptor gene — converging evidence for a role in panic disorder (2011) (164)
Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model (2003) (163)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. (2008) (162)
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders (2004) (160)
Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. (1994) (159)
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II (1995) (159)
Impaired Repression at a Vasopressin Promoter Polymorphism Underlies Overexpression of Vasopressin in a Rat Model of Trait Anxiety (2004) (158)
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression (2003) (158)
Soluble interleukin‐6 (IL‐6) receptor augments central effects of IL‐6 in vivo (1995) (158)
Cortisol Response to a Combined Dexamethasone‐Human Corticotrophin‐Releasing Hormone Challenge in Patients with Depression (1989) (158)
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats (2001) (157)
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology (2001) (157)
Low lumbar bone mineral density in patients with major depression. (1994) (156)
Progesterone-induced changes in sleep in male subjects. (1997) (153)
Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. (1985) (153)
Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. (1989) (152)
Glucocorticoids and depression. (1999) (150)
Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test (2003) (150)
Effects of transgenic overproduction of CRH on anxiety‐like behaviour (2002) (149)
Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (148)
Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling (2011) (147)
Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. (1996) (147)
Forebrain CRF1 Modulates Early-Life Stress-Programmed Cognitive Deficits (2011) (147)
Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression (2013) (145)
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies (2011) (145)
Behavioural performance in three substrains of mouse strain 129 (1997) (144)
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism (2006) (144)
Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. (1994) (144)
"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. (2005) (144)
Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin‐releasing hormone receptor‐dependent mechanism (2002) (144)
The female sex hormone oestrogen as a neuroprotectant. (1999) (141)
Increased sleep pressure reduces resting state functional connectivity (2010) (140)
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations (2008) (140)
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice (2008) (139)
Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants (1998) (139)
In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. (1995) (138)
Dreamed Movement Elicits Activation in the Sensorimotor Cortex (2011) (137)
Persistent Cognitive Impairment in Depression: The Role of Psychopathology and Altered Hypothalamic-Pituitary-Adrenocortical (HPA) System Regulation (2007) (136)
Heritability of Sleep Electroencephalogram (2008) (136)
Allopregnanolone affects sleep in a benzodiazepine-like fashion. (1997) (135)
Genetic Markers for PTSD Risk and Resilience Among Survivors of the World Trade Center Attacks (2011) (134)
Placental glucose transporter expression is regulated by glucocorticoids. (1999) (134)
Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression (2005) (133)
Interleukin‐1β Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the Rat (1995) (133)
Neuropeptides and human sleep. (1997) (133)
Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. (1998) (132)
Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men (2000) (132)
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. (2003) (132)
The Corticotropin-Releasing Hormone Network and the Hypothalamic-Pituitary-Adrenal Axis: Molecular and Cellular Mechanisms Involved (2011) (131)
Forced swimming evokes a biphasic response in CREB phosphorylation in extrahypothalamic limbic and neocortical brain structures in the rat (2002) (130)
Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss (2013) (128)
Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans (2014) (128)
Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. (1995) (127)
Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior (2008) (127)
Neuroendocrine and Behavioral Effects of Repetitive Transcranial Magnetic Stimulation in a Psychopathological Animal Model Are Suggestive of Antidepressant-like Effects (2001) (127)
Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways (2011) (126)
High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response (2007) (126)
Effects of rapid eye movement sleep deprivation on fear extinction recall and prediction error signaling (2012) (125)
Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects (1986) (125)
Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. (2003) (125)
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor (2003) (124)
Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. (1992) (123)
Effect of Ethanol on Hypothalamic–Pituitary–Adrenal System Response to Psychosocial Stress in Sons of Alcohol-Dependent Fathers (2004) (123)
Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. (1992) (122)
Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes (2010) (122)
Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. (1995) (122)
Human corticotropin-releasing hormone in depression—correlation with thyrotropin secretion following thyrotropin-releasing hormone (1986) (121)
Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients (2012) (121)
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. (2002) (120)
Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety (1998) (120)
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. (2005) (120)
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice (2008) (119)
Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. (2004) (119)
Corticotropin-releasing hormone modulators and depression. (2003) (118)
The modified hole board as a differential screen for behavior in rodents (2001) (117)
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. (1997) (117)
ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression (1984) (116)
Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. (1995) (115)
Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. (1987) (113)
The neural correlates and temporal sequence of the relationship between shock exposure, disturbed sleep and impaired consolidation of fear extinction. (2010) (113)
Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. (2009) (113)
Rapid eye movement-related brain activation in human sleep: a functional magnetic resonance imaging study (2005) (113)
HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients (2009) (112)
Maintenance of hippocampal cell numbers in young and aged rats submitted to chronic unpredictable stress. Comparison with the effects of corticosterone treatment. (1998) (112)
Reduced hippocampus volume in the mouse model of Posttraumatic Stress Disorder. (2011) (111)
CRF signaling: molecular specificity for drug targeting in the CNS. (2006) (111)
Impact of high and low anxiety on cognitive performance in a modified hole board test in C57BL/6 and DBA/2 mice (2003) (111)
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS (1999) (110)
The activated glucocorticoid receptor inhibits the transcription factor T‐bet by direct protein‐protein interaction (2007) (109)
Meta-analysis of genome-wide association data detects a risk locus for major mood disorders on chromosome 3p21.1 (2009) (109)
Influence of endotoxin on nocturnal sleep in humans. (1993) (109)
Refining genetic associations in multiple sclerosis (2008) (108)
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. (2006) (108)
Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder (2008) (108)
DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. (1995) (108)
Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome (2008) (108)
Sleep in Schizophrenia: A Polysomnographic Study on Drug-Naive Patients (1997) (107)
Protection Against Oxidative Stress‐induced Neuronal Cell Death‐A Novel Role for RU486 (1997) (106)
Dysregulation of the Hypothalamic-Pituitary-Adrenocortical System in Panic Disorder (1996) (105)
ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery (1985) (105)
Mice with Mutations in the HPA-System as Models for Symptoms of Depression (2006) (105)
Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. (1997) (104)
Successful Antidepressant Therapy Restores the Disturbed Interplay Between TNF-α System and HPA Axis (2006) (104)
The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. (2000) (104)
Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test. (2001) (104)
The hypothalamic-pituitary-adrenocortical system and sleep in man. (1995) (103)
Regulation of the Hypothalamic-Pituitary-Adrenocortical System in Mice Deficient for CRH Receptors 1 and 2. (2001) (102)
Evidence supporting the match/mismatch hypothesis of psychiatric disorders (2014) (102)
Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice (2000) (101)
Intact spatial learning and memory in transgenic mice with reduced BDNF (1997) (101)
Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls. (1984) (100)
High susceptibility to chronic social stress is associated with a depression-like phenotype (2010) (100)
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas (2005) (99)
Pharmacogenomics and antidepressant drugs (2006) (98)
Methylation at the CpG island shore region upregulates Nr3c1 promoter activity after early-life stress (2015) (98)
Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep (2009) (97)
Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production (2000) (96)
INCREASED BASAL ACTIVITY OF THE HYPOTHALAMO–PITUITARY–ADRENAL AXIS DURING PREGNANCY IN RATS BRED FOR HIGH ANXIETY-RELATED BEHAVIOUR (1998) (96)
A novel chronic social stress paradigm in female mice (2010) (95)
Endocrine disturbances in depression (2005) (95)
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders (2015) (95)
Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway (1996) (94)
The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism (2004) (94)
EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units (2011) (94)
Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine (2008) (93)
Intraperitoneal Administration of Bacterial Endotoxin Enhances Noradrenergic Neurotransmission in the Rat Preoptic Area: Relationship with Body Temperature and Hypothalamic‐Pituitary‐Adrenocortical Axis Activity (1995) (92)
Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression‐like behaviour: effects of chronic paroxetine treatment (2005) (92)
Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. (2010) (92)
Neurosteroids: Molecular mechanisms of action and psychopharmacological significance (1996) (91)
Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro (1995) (91)
Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone (1991) (91)
Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice (2006) (91)
Neuropsychopharmacological properties of neuroactive steroids (1999) (91)
Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression (2010) (91)
Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. (2010) (90)
Steroid Effects on Central Neurons and Implications for Psychiatric and Neurological Disorders (1994) (90)
Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. (1996) (90)
β2-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein βγ-subunits and the phosphoinositide 3-kinase pathway. (2001) (90)
Genetics of stress response and stress-related disorders (2006) (89)
Protein Biomarkers in a Mouse Model of Extremes in Trait Anxiety* (2006) (89)
Regulation of the Hypothalamic–Pituitary–Adrenocortical System in Patients with Panic Disorder (2006) (89)
Diurnal variations in the human host response to endotoxin. (1996) (88)
Antidepressant Drugs Diversely Affect Autophagy Pathways in Astrocytes and Neurons—Dissociation from Cholesterol Homeostasis (2011) (88)
Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. (1995) (87)
ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder (2003) (87)
DIAGNOSTIC VALUE OF DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION (1980) (87)
Early‐life stress‐induced anxiety‐related behavior in adult mice partially requires forebrain corticotropin‐releasing hormone receptor 1 (2012) (87)
Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats (1999) (87)
Blunted aldosterone and ACTH release after human CRH administration in depressed patients. (1987) (87)
Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology (2012) (87)
Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression (2000) (87)
Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. (1995) (86)
Individual Stress Vulnerability Is Predicted by Short-Term Memory and AMPA Receptor Subunit Ratio in the Hippocampus (2010) (86)
Antidepressants and Antipsychotic Drugs Colocalize with 5-HT3 Receptors in Raft-Like Domains (2005) (86)
Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulation (1993) (85)
Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. (1987) (84)
Metabolic Signals Modulate Hypothalamic‐Pituitary‐Adrenal Axis Activation During Maternal Separation of the Neonatal Mouse (2006) (84)
Inhibition of macrophage differentiation and function by cortisol. (1990) (84)
Glucocorticoids inhibitGATA‐3 phosphorylation and activity in T cells (2009) (84)
Effects of pulsatile cortisol infusion on sleep‐EEG and nocturnal growth hormone release in healthy men (1994) (84)
The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. (1994) (82)
Effects of Genetic Background, Gender, and Early Environmental Factors on Isolation-Induced Ultrasonic Calling in Mouse Pups: An Embryo-Transfer Study (2008) (82)
Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers--a potential link to low-melatonin syndrome in depression? (1997) (82)
Cross-Fostering and Cross-Breeding of HAB and LAB Rats: A Genetic Rat Model of Anxiety (2001) (81)
Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: a combined in vivo microdialysis/EEG study in rats (2003) (81)
Urocortin 3 Modulates Social Discrimination Abilities via Corticotropin-Releasing Hormone Receptor Type 2 (2010) (81)
Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. (1994) (81)
The Munich Vulnerability Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands (2005) (81)
Implications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depression (1988) (81)
Nocturnal plasma levels of cytokines in healthy men (2005) (80)
Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry (2004) (80)
Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. (1994) (80)
Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse (1989) (79)
γ‐Glutamylglutamine and Taurine Concentrations Are Decreased in the Cerebrospinal Fluid of Drug‐Naive Patients with Schizophrenic Disorders (1995) (79)
Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats (2000) (79)
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation (2012) (79)
Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function (1998) (78)
Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment (1988) (78)
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis (2010) (78)
Depletion of the neural precursor cell pool by glucocorticoids (2010) (78)
Increased activity of the hypothalamus–pituitary–adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone (2000) (77)
Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences. (2009) (77)
Proteomic and Metabolomic Profiling of a Trait Anxiety Mouse Model Implicate Affected Pathways* (2011) (77)
Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties (2015) (77)
Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. (2007) (77)
Neuronal actions of glucocorticoids: Focus on depression (2008) (77)
Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. (1996) (76)
Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons (2012) (75)
Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients (1998) (75)
Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. (1996) (75)
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. (2012) (75)
On the role of corticotropin-releasing hormone receptors in anxiety and depression (2002) (75)
Unstable Prefrontal Response to Emotional Conflict and Activation of Lower Limbic Structures and Brainstem in Remitted Panic Disorder (2009) (74)
The Prospect of FKBP51 as a Drug Target (2012) (74)
Somatostatin Impairs Sleep in Elderly Human Subjects (1997) (74)
Rhythmicity in Mice Selected for Extremes in Stress Reactivity: Behavioural, Endocrine and Sleep Changes Resembling Endophenotypes of Major Depression (2009) (73)
Cortisol, 11-deoxycortisol, and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers (1984) (73)
Identification and characterization of HPA-axis reactivity endophenotypes in a cohort of female PTSD patients (2015) (73)
Regulation of interleukin 6 gene expression in rat. (1993) (73)
A Hypomorphic Vasopressin Allele Prevents Anxiety-Related Behavior (2009) (73)
Transcriptional Activities of the Zinc Finger Protein Zac Are Differentially Controlled by DNA Binding (2003) (73)
Met and unmet needs in the management of depressive disorder in the community and primary care: the size and breadth of the problem. (2001) (73)
Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG (2004) (72)
Glucocorticoid receptor blockade disinhibits pituitary-adrenal activity during the stress hyporesponsive period of the mouse. (2005) (72)
Reduced Leptin Levels in Human Narcolepsy (2000) (72)
Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis (2003) (71)
Pre-morbid psychometric profile of subjects at high familial risk for affective disorder (1997) (71)
Gender differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection (2003) (71)
Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice (2002) (70)
Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. (2009) (70)
Altered Serotonergic Neurotransmission but Normal Hypothalamic–Pituitary–Adrenocortical Axis Activity in Mice Chronically Treated with the Corticotropin-Releasing Hormone Receptor Type 1 Antagonist NBI 30775 (2003) (70)
Increased ACTH Concentrations Associated with Cholecystokinin Tetrapeptide-Induced Panic Attacks in Patients with Panic Disorder (2000) (70)
Acoustic Oddball during NREM Sleep: A Combined EEG/fMRI Study (2009) (70)
Cortisol Enhances non-REM Sleep and Growth Hormone Secretion in Elderly Subjects (1997) (69)
The dexamethasone suppression test in depressed patients: clinical and biochemical aspects. (1983) (69)
Pregnenolone enhances EEG delta activity during non-rapid eye movement sleep in the rat, in contrast to midazolam (1994) (69)
Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder (2007) (69)
Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats (1999) (69)
Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. (1995) (68)
Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders (2005) (68)
FKBP5 Genotype-Dependent DNA Methylation and mRNA Regulation After Psychosocial Stress in Remitted Depression and Healthy Controls (2015) (68)
Outcomes of 1014 naturalistically treated inpatients with major depressive episode (2010) (68)
HTR2A gene variation is involved in antidepressant treatment response (2010) (68)
Corticotropin‐releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat (1994) (67)
On the Gender Differences in Sleep-Endocrine Regulation in Young Normal Humans (1999) (67)
Transcription factor‐mediated molecular mechanisms involved in the functional cross‐talk between cytokines and glucocorticoids (2001) (66)
Differential induction of NF‐κB activity and neural cell death by antidepressants in vitro (2000) (65)
Genetic modification of corticosteroid receptor signalling: Novel insights into pathophysiology and treatment strategies of human affective disorders (2002) (65)
Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice (2016) (65)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis (2005) (65)
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats (2004) (65)
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner (2004) (65)
Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity (2004) (64)
Cognitive performance in rats differing in their inborn anxiety. (2002) (64)
Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. (2002) (64)
Dendritic Morphology of Hippocampal and Amygdalar Neurons in Adolescent Mice Is Resilient to Genetic Differences in Stress Reactivity (2012) (64)
The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. (2001) (63)
Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. (2001) (63)
Mechanisms Underlying the Protective Potential of α-Tocopherol (Vitamin E) against Haloperidol-associated Neurotoxicity (2002) (63)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study (2013) (63)
Neural correlates of insight in dreaming and psychosis. (2015) (62)
Acute adrenocortical stimulation by recombinant gamma interferon in human controls. (1988) (62)
Selective Activation of the Hypothalamic Vasopressinergic System in Mice Deficient for the Corticotropin-Releasing Hormone Receptor 1 Is Dependent on Glucocorticoids* * This work was supported by the Volkswagen Stiftung (to F.H. and W.W.). (2000) (62)
Evidence for the role of corticotropin-releasing factor in major depressive disorder (2015) (62)
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations (2006) (62)
Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. (1995) (61)
ABCB1 gene variants and antidepressant treatment outcome: A meta‐analysis (2015) (61)
Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro. (1993) (61)
The plasma dexamethasone variable in depression: Test- retest studies and early biophase kinetics (1986) (61)
Are there meaningful biomarkers of treatment response for depression? (2014) (61)
Effect of flumazenil in lactate-sensitive patients with panic disorder. (1998) (60)
Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship. (1996) (60)
Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. (1994) (60)
Activity of the hypothalamic–pituitary–adrenal axis in multiple sclerosis: Correlations with gadolinium‐enhancing lesions and ventricular volume (2002) (60)
Mild deficits in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks. (2000) (60)
Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function. (1997) (60)
The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. (2003) (60)
Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. (1996) (59)
Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition (2011) (59)
Family history of depression is associated with younger age of onset in patients with recurrent depression (2008) (59)
Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder (2000) (58)
Homer1 Mediates Acute Stress-Induced Cognitive Deficits in the Dorsal Hippocampus (2013) (58)
The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders (2008) (58)
Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters. (2013) (58)
State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine (2003) (58)
Essential Role of the Unusual DNA-binding Motif of BAG-1 for Inhibition of the Glucocorticoid Receptor* 210 (2003) (58)
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. (2009) (58)
Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. (1991) (58)
Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. (2008) (57)
Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. (2001) (57)
Phenome-transcriptome correlation unravels anxiety and depression related pathways. (2011) (57)
In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls (1998) (57)
A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder (2015) (57)
Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation. (2011) (56)
Glucocorticoid repression of 3',5'-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line. (1990) (56)
Acute Cortisol Administration Promotes Sleep Intensity in Man (2004) (56)
Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder (1999) (55)
Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response (2010) (55)
Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders (1992) (55)
Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. (2010) (55)
Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. (1995) (55)
Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST. (1983) (54)
Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors. (1986) (54)
Enhancement of rat splenic lymphocyte mitogenesis after short term preexposure to corticosteroids in vitro. (1994) (54)
Reduced Efficacy of Growth Hormone-Releasing Hormone in Modulating Sleep Endocrine Activity in the Elderly (1997) (53)
Alterations of nocturnal sleep in patients with HIV infection (1991) (53)
Corticotropin releasing factor receptor antagonists for major depressive disorder (2011) (53)
Differences in FKBP51 Regulation Following Chronic Social Defeat Stress Correlate with Individual Stress Sensitivity: Influence of Paroxetine Treatment (2012) (53)
The sleep eeg and nocturnal hormonal secretion studies on changes during the course of depression and on effects of cns-active drugs (1993) (52)
Plasticity of hippocampal corticosteroid receptors during aging in the rat (1999) (52)
Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation. (1996) (52)
Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus (2012) (52)
IGF-I in major depression and antidepressant treatment response (2015) (52)
Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. (1989) (51)
Lipopolysaccharide increases EEG delta activity within non-REM sleep and disrupts sleep continuity in rats. (1995) (51)
Central and peripheral administration of atriopeptin is anxiolytic in rats. (1997) (51)
Genome Wide Association Analysis of Copy Number Variation in Recurrent Depressive Disorder (2011) (51)
Endocrine and behavioral effects of airpuff-startle in rats (1996) (51)
The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. (2002) (51)
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications (2016) (50)
CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues (2009) (50)
Therapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder (2013) (50)
Integrating Systemic Information at the Molecular Level (2003) (50)
The Munich vulnerability study on affective disorders: stability of polysomnographic findings over time (2002) (50)
CRH Signaling (2009) (49)
Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. (2000) (49)
Human corticotropin releasing hormone: Clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls (1988) (49)
CORTICOTROPIN-RELEASING-FACTOR INDUCED PITUITARY-ADRENAL RESPONSE IN DEPRESSION (1984) (49)
Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis status in healthy males (2013) (49)
Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology (1985) (49)
Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals† (2017) (49)
Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. (2000) (49)
Estimating the heritability of reporting stressful life events captured by common genetic variants (2012) (48)
Nocturnal hormone secretion and the sleep EEG in patients several months after traumatic brain injury. (1999) (48)
AKT/GSK-3β/β-catenin signalling within hippocampus and amygdala reflects genetically determined differences in posttraumatic stress disorder like symptoms (2010) (48)
Oxidative stress-resistant cells are protected against haloperidol toxicity (1996) (48)
Reduced attention in mice overproducing corticotropin-releasing hormone (2003) (48)
Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. (1995) (48)
Bidirectional rescue of extreme genetic predispositions to anxiety: impact of CRH receptor 1 as epigenetic plasticity gene in the amygdala (2014) (48)
CRH-sub-1 receptor antagonists for the treatment of depression and anxiety. (2007) (48)
Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping. (1995) (48)
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. (2001) (48)
Prediction of antidepressant treatment response from gray matter volume across diagnostic categories (2013) (48)
Hypothalamic-pituitary-adrenal axis function in elderly endurance athletes. (1991) (47)
Disrupted allocentric but preserved egocentric spatial learning in transgenic mice with impaired glucocorticoid receptor function (1999) (47)
Long-Lasting Hippocampal Synaptic Protein Loss in a Mouse Model of Posttraumatic Stress Disorder (2012) (47)
Glucocorticoid and mineralocorticoid receptors in rat neocortical and hippocampal brain cells in culture: characterization and regulatory studies (1993) (47)
The stress hormone system is back on the map (2000) (47)
The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: An in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice (2007) (47)
Profiling Trait Anxiety: Transcriptome Analysis Reveals Cathepsin B (Ctsb) as a Novel Candidate Gene for Emotionality in Mice (2011) (47)
The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. (2005) (46)
Endotoxin enhances EEG alpha and beta power in human sleep. (1994) (46)
Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. (2016) (46)
Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. (2013) (46)
Beta(2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. (2001) (46)
Activation of c-Fos contributes to amyloid β-peptide-induced neurotoxicity (1996) (46)
RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity (2013) (45)
Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects. (1997) (45)
Sonic hedgehog regulates CRH signal transduction in the adult pituitary (2005) (45)
Nocturnal sleep EEG in patients with HIV infection (1991) (45)
Expression of CRHR1 and CRHR2 in Mouse Pituitary and Adrenal Gland: Implications for HPA System Regulation. (2001) (44)
Epigenetic Aspects of Posttraumatic Stress Disorder (2011) (44)
The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation. (1998) (44)
Increased anxiety-related behaviour in Hint1 knockout mice (2011) (44)
Four cases of reversion to abnormal dexamethasone suppression test response as indicator of clinical relapse: a preliminary report. (1983) (44)
Rifampicin is not an activator of glucocorticoid receptor. (2000) (44)
Inhibition of GR‐mediated transcription by p23 requires interaction with Hsp90 (2004) (44)
Regulation of the developing hypothalamic–pituitary–adrenal axis in corticotropin releasing hormone receptor 1-deficient mice (2003) (44)
Cofilin 1 Is Revealed as an Inhibitor of Glucocorticoid Receptor by Analysis of Hormone-Resistant Cells (2004) (43)
Nuclear Orphan Receptor as a Repressor of Glucocorticoid Receptor Transcriptional Activity (*) (1996) (43)
VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. (1996) (43)
Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. (1997) (43)
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients (2011) (43)
Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking (2009) (43)
Changes in the Hypothalamic-Pituitary-Adrenal Axis and Leptin Levels during Antidepressant Treatment (2007) (42)
Release of vasopressin and oxytocin within the brain and into blood: microdialysis and antisense targeting (1995) (42)
Panic disorder and major depression: A comparative electroencephalographic sleep study (1992) (42)
Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. (1998) (42)
Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. (1996) (42)
Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms (2011) (42)
XAP2 inhibits glucocorticoid receptor activity in mammalian cells (2009) (41)
Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation (2011) (41)
Mirtazapine provokes periodic leg movements during sleep in young healthy men. (2012) (41)
Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug (1987) (41)
Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells (2012) (41)
Neuroscience-driven discovery and development of sleep therapeutics. (2014) (41)
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice (2010) (41)
Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice (2012) (41)
Disruption of feeding behavior in CRH receptor I‐deficient mice is dependent on glucocorticoids (2000) (41)
Increased HPA axis response to psychosocial stress in remitted depression: the influence of coping style (2014) (40)
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. (2006) (40)
Hypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant Mice (2004) (40)
Changes in Sleep‐Endocrine Activity after Growth Hormone‐Releasing Hormone Depend on Time of Administration (1997) (40)
Glucocorticoid Regulation of Astrocytic Fate and Function (2011) (40)
The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. (2003) (40)
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers (1998) (40)
Association between copy number variants in 16p11.2 and major depressive disorder in a German case–control sample (2012) (40)
Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism (2012) (40)
Central deficiency of corticotropin-releasing hormone receptor type 1 (CRH-R1) abolishes effects of CRH on NREM but not on REM sleep in mice. (2010) (40)
Deficiency of FK506‐binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice (2014) (40)
Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation. (2001) (40)
Diabetes insipidus and, partially, low anxiety‐related behaviour are linked to a SNP‐associated vasopressin deficit in LAB mice (2007) (39)
Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways (2010) (39)
Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission (1997) (39)
Serial partial sleep deprivation in depression--clinical effects and dexamethasone suppression test results. (1988) (39)
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats (1994) (39)
Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation. (2006) (39)
Sleep disturbances in highly stress reactive mice: Modeling endophenotypes of major depression (2011) (39)
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors (2014) (39)
Childhood abuse and depression in adulthood: The mediating role of allostatic load (2018) (39)
Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide (1998) (38)
Mean 14.00–17.00 h plasma cortisol concentration and its relationship to the 1 mg‐dexamethasone suppression response in depressives and controls (1984) (38)
The Munich Vulnerability Study on Affective Disorders: risk factors for unipolarity versus bipolarity. (2003) (38)
Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. (1997) (38)
Central Administration of IL-1 Reduces Anxiety and Induces Sickness Behaviour in Rats (1997) (38)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression (2019) (38)
Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent inhibition and reversal learning deficits in highly stress reactive mice (2010) (38)
Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. (2003) (38)
Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse (1988) (38)
Using Polymorphisms in FKBP 5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder Evidence From Endocrine and Gene Expression Studies (2011) (37)
Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol (1986) (37)
Differential disinhibition of the neonatal hypothalamic– pituitary–adrenal axis in brain‐specific CRH receptor 1‐knockout mice (2006) (37)
Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol. A comparative study in men. (1993) (37)
Ten years of Nature Reviews Neuroscience: insights from the highly cited (2010) (37)
On the Need of Objective Vigilance Monitoring: Effects of Sleep Loss on Target Detection and Task-Negative Activity Using Combined EEG/fMRI (2012) (37)
Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. (2001) (37)
Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences. (1998) (36)
Impact of Lipid Raft Integrity on 5-HT3 Receptor Function and its Modulation by Antidepressants (2009) (36)
The GABAA receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone (1999) (36)
Polymorphisms in the GAD2 gene‐region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders (2009) (36)
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. (2005) (36)
Antidepressant Drug Discovery in the Postgenomic Era (2001) (36)
Oxidativer Stress in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion. (1998) (35)
Antidepressants Differentially Influence the Transcriptional Activity of the Glucocorticoid Receptor in vitro (2003) (35)
Open clinical trial on the sigma ligand panamesine in patients with schizophrenia (1997) (35)
Self-reported sleep quality in HIV infection: correlation to the stage of infection and zidovudine therapy. (1991) (35)
Hippocampal N-acetylaspartate Levels Before Trauma Predict the Development of Long-Lasting Posttraumatic Stress Disorder-like Symptoms in Mice (2009) (35)
Handbuch der Psychopharmakotherapie (2008) (35)
Polymorphisms in the angiotensin‐converting enzyme gene region predict coping styles in healthy adults and depressed patients (2009) (35)
Heterozygosity for the Mood Disorder-Associated Variant Gln460Arg Alters P2X7 Receptor Function and Sleep Quality (2017) (35)
Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex (2018) (34)
Circadian changes in the sensitivity of the corticotropin-releasing hormones-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls (1995) (34)
The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects (2008) (34)
Cytokine Expression and Molecular Mechanisms of Their Auto/Paracrine Regulation of Anterior Pituitary Function and Growth (1998) (34)
Activation of CRH receptor type 1 expressed on glutamatergic neurons increases excitability of CA1 pyramidal neurons by the modulation of voltage-gated ion channels (2013) (34)
Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action (2009) (34)
Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. (2004) (34)
Consequences of chronic social stress on behaviour and vasopressin gene expression in the PVN of DBA/2OlaHsd mice—influence of treatment with the CRHR1-antagonist R121919/NBI 30775 (2009) (34)
Voltage-sensitive dye imaging demonstrates an enhancing effect of corticotropin-releasing hormone on neuronal activity propagation through the hippocampal formation. (2011) (33)
Serotonin reuptake inhibitors and DST status. (1987) (33)
The role of peptides in treatment of psychiatric disorders. (2003) (33)
Effects of an ACTH/MSH(4–9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans (1991) (33)
Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity. (1993) (33)
The glucocorticoid sensitivity of lymphocytes changes according to the activity of the hypothalamic-pituitary-adrenocortical system (1995) (33)
Psychometric, polysomnographic, and neuroendocrine measures in subjects at high risk for psychiatric disorders: preliminary results. (1990) (33)
Activational Effects of Gonadal Steroids on Hypothalamo‐Pituitary‐Adrenal Regulation in the Rat Disclosed by Response to Dexamethasone Suppression (1997) (33)
Dexamethasone suppression test in severe schizophrenic illness: Effects of plasma dexamethasone and caffeine levels (1987) (33)
Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men. (1994) (33)
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. (2001) (32)
Assessing Behavioural Effects of Chronic HPA Axis Activation Using Conditional CRH-Overexpressing Mice (2012) (32)
Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. (2007) (32)
Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. (1999) (32)
Toward a Reliable Distinction Between Patients with Mild Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression (2006) (32)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels (2013) (32)
Animal models of mood disorders. (1999) (32)
Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia. (1995) (31)
Erratum: Effects of transgenic overproduction of CRH on anxiety-like behaviour (European Journal of Neuroscience (2002) 15 (2007-2015)) (2002) (31)
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'. (2001) (31)
Activity of the GR in G2 and mitosis. (2002) (31)
Susceptibility and Resistance to Experimental Allergic Encephalomyelitis: Relationship with Hypothalamic-Pituitary-Adrenocortical Axis Responsiveness in the Rat2. (1999) (31)
RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response (2015) (31)
Effect of Sulpiride in Endogenous Depression (1984) (31)
Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge (2005) (30)
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression (2004) (30)
Transrepression of NF-κB is not required for glucocorticoid-mediated protection of TNF-α-induced apoptosis on fibroblasts (2000) (30)
Maternal inexperience as a risk factor of innate fear and PTSD-like symptoms in mice. (2009) (30)
Dexamethasone stimulated gene expression in peripheral blood indicates glucocorticoid-receptor hypersensitivity in job-related exhaustion (2013) (30)
The CpG island shore of the GLT‐1 gene acts as a methylation‐sensitive enhancer (2012) (30)
Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function (1999) (30)
Searching for non-genetic molecular and imaging PTSD risk and resilience markers: Systematic review of literature and design of the German Armed Forces PTSD biomarker study (2015) (30)
Atrial Natriuretic Hormone Decreases Endocrine Response to a Combined Dexamethasone–Corticotropin-Releasing Hormone Test (1998) (30)
Neuroactive steroids in neuropsychopharmacology. (2001) (30)
Morphine‐Induced Locomotor and Neurochemical Stimulation is Enhanced in Transgenic Mice with Impaired Glucocorticoid Receptor Function (1996) (30)
Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. (2004) (29)
Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug. (1987) (29)
Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation. (2008) (29)
Intracellular Molecular Signaling (2009) (29)
Prospects for antidepressant drug discovery (2001) (29)
B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells. (2013) (29)
Age‐ and stimulus‐dependent changes in anxiety‐related behaviour of transgenic mice with GR dysfunction (1998) (29)
Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds. (2013) (28)
Effects of granulocyte colony-stimulating factor on night sleep in humans. (1999) (28)
Multisteroid analysis after DST in depressed patients--a controlled study. (1986) (28)
Genetic Architecture of Subcortical Brain Structures in Over 40,000 Individuals Worldwide (2017) (28)
Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism (2003) (28)
Functional Cross‐talk among Cytokines, T‐Cell Receptor, and Glucocorticoid Receptor Transcriptional Activity and Action (2000) (28)
Bcl-2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol (1996) (27)
Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis (2009) (27)
C-type natriuretic peptide exerts effects opposing those of atrial natriuretic peptide on anxiety-related behaviour in rats (1998) (27)
Activity patterns as a correlate for sleep–wake behaviour in mice (2004) (27)
Dexamethasone suppression test in female patients with endogenous depression: determinations of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, cortisol and cortisone (1982) (27)
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression. (1987) (27)
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis (1999) (27)
Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males. (1994) (27)
Expression Profiling Identifies the CRH/CRH-R1 System as a Modulator of Neurovascular Gene Activity (2007) (26)
Dehydroepiandrosterone Response to the Adrenocorticotropin Test and the Combined Dexamethasone and Corticotropin-Releasing Hormone Test in Patients with Multiple Sclerosis (1999) (26)
Changes in MAO activity during estrogen treatment of females with endogenous depression. (1983) (26)
Functional antagonistic properties of clozapine at the 5-HT3 receptor. (1996) (26)
Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients (2001) (26)
Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder (2016) (26)
Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. (2000) (26)
Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity (2017) (26)
Increased splenocyte proliferative response and cytokine production in β-endorphin-deficient mice (2002) (26)
Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats (1994) (26)
Immune-endocrine host response to endotoxin in major depression. (2007) (26)
Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response (2012) (26)
B-HT920 - A Novel Dopamine Autoreceptor Agonist in the Treatment of Patients with Schizophrenia (1990) (26)
Genetic Determinants of Cortical Structure (Thickness, Surface Area and Volumes) among Disease Free Adults in the CHARGE Consortium (2018) (26)
Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients (2012) (26)
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. (2010) (26)
More CLEC16A gene variants associated with multiple sclerosis (2011) (26)
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder (2008) (25)
The Neuroactive Steroid 5α‐Tetrahydrodeoxycorticosterone Increases GABAergic Postsynaptic Inhibition in Rat Neocortical Neurons in vitro (1995) (25)
Transcriptional induction of rat mineralocorticoid receptor gene in neurones by corticosteroids. (1995) (25)
Early life stress determines the effects of glucocorticoids and stress on hippocampal function: Electrophysiological and behavioral evidence respectively (2018) (25)
Mouse Mutants for the Study of Corticotropin‐Releasing Hormone Receptor Function: Development of Novel Treatment Strategies for Mood Disorders (2004) (25)
The pre-morbid psychometric profile is stable over time in subjects at high familial risk for affective disorders. (1998) (25)
Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. (2001) (25)
CRHR1 Antagonists as Novel Treatment Strategies (2001) (25)
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. (2007) (25)
Effects of ethanol administration and induction of anxiety-related affective states on the acoustic startle reflex in sons of alcohol-dependent fathers. (2004) (25)
A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies (2015) (25)
Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controls (1995) (25)
Ziprasidone-related tardive dyskinesia. (2004) (25)
Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a 5‐HT1A receptor challenge (2002) (24)
Impaired glucocorticoid receptor function evolves in aberrant physiological responses to bacterial endotoxin (1999) (24)
Hyporesponsiveness of the Pituitary to CRH during Slow Wave Sleep Is Not Mimicked by Systemic GHRH (1999) (24)
Cytokines in the Healthy and Diseased Brain (1994) (24)
[Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection]. (1998) (24)
Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response (2014) (24)
Low Cortisol and Risk and Resilience to Stress-Related Psychiatric Disorders (2012) (24)
Effects of Thyrotropin-Releasing Hormone on the Sleep EEG and Nocturnal Hormone Secretion in Male Volunteers (1998) (24)
High‐Quality Antidepressant Discovery by Understanding Stress Hormone Physiology (2003) (24)
Nur77 induction and activation are necessary for interleukin‐1 stimulation of proopiomelanocortin in AtT‐20 corticotrophs (2004) (24)
Early Activation of Thyrotropin-Releasing-Hormone and Prolactin Plays a Critical Role during a T Cell-Dependent Immune Response. (1999) (24)
Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen (1986) (24)
Unravelling the GSK3&bgr;-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder (2018) (23)
Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters (2005) (23)
The Th1 and Th2 cytokines IFN‐γ and IL‐4 antagonize the inhibition of monocyte IL‐1 receptor antagonist by glucocorticoids: involvement of IL‐1 (1998) (23)
High doses of systemic DHEA-sulfate do not affect sleep structure and elicit moderate changes in non-REM sleep EEG in rats (2000) (23)
A follow‐up case–control association study of tractable (druggable) genes in recurrent major depression (2011) (23)
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis (2014) (23)
Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men. (1998) (23)
Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis (2013) (23)
Dexamethasone suppression of 11‐deoxycorticosterone, corticosterone and cortisol in depressed female patients and normal controls (1982) (23)
Increased sensitivity of the dexamethasone suppression test in depressed female patients based on multisteroid analysis (1983) (22)
New mode of hypothalamic-pituitary-adrenocortical axis regulation: significance for stress-related disorders (2000) (22)
Intranasally Applied Neuropeptide S Shifts a High-Anxiety Electrophysiological Endophenotype in the Ventral Hippocampus towards a "Normal"-Anxiety One (2015) (22)
Psychopathological correlates of plasma cortisol after dexamethasone suppression: A polydiagnostic approach (1986) (22)
Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. (2008) (22)
The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51 (2016) (22)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression (2010) (22)
Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression (2019) (22)
ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. (2012) (22)
Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance. (1994) (22)
Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial. (2009) (22)
Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks (2008) (21)
Relationship between baseline severity of depression and antidepressant treatment outcome. (2010) (21)
RSUME inhibits VHL and regulates its tumor suppressor function (2014) (21)
Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice (2001) (21)
Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats. (1998) (20)
Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia. (1997) (20)
Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919) (2005) (20)
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS (2000) (20)
Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. (2000) (20)
SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system (2016) (20)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach (2014) (20)
Intrahippocampal Corticosterone Response in Mice Selectively Bred for Extremes in Stress Reactivity: A Microdialysis Study (2010) (20)
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. (2015) (20)
Phosphopeptide enrichment by IEF (2006) (20)
Real-Time Imaging of Amygdalar Network Dynamics In Vitro Reveals a Neurophysiological Link to Behavior in a Mouse Model of Extremes in Trait Anxiety (2013) (19)
Molecular mechanisms of glucocorticoid receptor signaling. (2010) (19)
X-ray photoelectron and mössbauer spectroscopy on five-coordinated iridium(I) complexes (1973) (19)
CRE-mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. (2002) (19)
Corticosterone modulates interleukin-evoked fever in the rat. (1994) (19)
Allopregnanolone acts as an inhibitory modulator on α1-and α6-containing GABAΑ receptors (1996) (19)
The endocrinology of mental disease (1992) (19)
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function (2016) (19)
A polymorphism in the Crhr1 gene determines stress vulnerability in male mice. (2014) (19)
Plasma fibrinogen: now also an antidepressant response marker? (2014) (19)
The hypothalamic-pituitary-adrenocortical system (1992) (19)
The Munich vulnerability study on affective disorders: premorbid psychometric profile of affected individuals (2004) (19)
Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion. (1991) (19)
Blunted aldosterone response to dexamethasone in female patients with endogenous depression (1982) (19)
Zotepin versus Perazin bei Patienten mit paranoider Schizophrenie: eine doppelblind-kontrollierte Wirksamkeitsprüfung (1991) (18)
Effects of brofaremine (CGP 11 305A), a short-acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturnal hormonal secretion in three healthy volunteers (2004) (18)
Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls (1993) (18)
Genetics of rapid eye movement sleep in humans (2015) (18)
Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response. (2017) (18)
Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression (1989) (18)
Temazepam Triggers the Release of Vasopressin into the Rat Hypothalamic Paraventricular Nucleus: Novel Insight into Benzodiazepine Action on Hypothalamic–Pituitary–Adrenocortical System Activity During Stress (2006) (17)
Non‐response to antidepressants: risk factors and therapeutic possibilities (1988) (17)
Antiglucocorticoid treatment disrupts endocrine cycle and nocturnal sleep pattern (2005) (17)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression (2010) (17)
Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes (2012) (17)
Acute and chronic neuroendocrine effects of interferon‐β 1a in multiple sclerosis (2007) (17)
Acute stress regulation of neuroplasticity genes in mouse hippocampus CA3 area — Possible novel signalling pathways (2008) (17)
Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA‐activated Cl− currents in cultured rat hypothalamic neurons (1999) (17)
Conditioned activity to amphetamine in transgenic mice expressing an antisense RNA against the glucocorticoid receptor. (2001) (17)
Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity. (1996) (17)
Therapeutics for depression and anxiety disorders (2004) (17)
Glucocorticoid receptor impairment enhances impulsive responding in transgenic mice performing on a simultaneous visual discrimination task (2000) (17)
Determination of urinary 17-hydroxypregnanolone by gas chromatography-mass spectrometry in patients with congenital adrenal hyperplasia. (1977) (16)
Peripheral and central regulation of IL-6 gene expression in endotoxin-treated rats. (1992) (16)
Ethanol administration dampens the prolactin response to psychosocial stress exposure in sons of alcohol-dependent fathers (2009) (16)
The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST. (1990) (16)
Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls. (1989) (16)
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats. (1998) (16)
[Neuroendocrinologic and endocrinologic research in depressive patients]. (1985) (16)
Hypnotics and sleep physiology: A consensus repot (2005) (16)
Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including Amyloid beta Precursor Protein (2010) (16)
Intrahypothalamic neuroendocrine actions of corticotropin-releasing factor. (1993) (16)
Rapid double bond shift in a donor-acceptor substituted cyclobutadiene. Evidence from 584-Ang and x-ray photoelectron spectroscopy (1973) (15)
New insights into the intracellular distribution pattern of cationic amphiphilic drugs (2017) (15)
Cordance derived from REM sleep EEG as a biomarker for treatment response in depression--a naturalistic study after antidepressant medication. (2015) (15)
The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety (2012) (15)
Zur Elektronenstruktur der Thiokumulene / The Electronic Structure of Thiocumulenes (1973) (15)
Psychiatric disorders biomarker identification: from proteomics to systems biology. (2008) (15)
Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress (2008) (15)
Differential effects of the enantiomers R(−) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: Studies on depressed patients and normal controls (1993) (15)
Conditional CRH overexpressing mice: an animal model for stress-elicited pathologies and treatments that target the central CRH system (2008) (15)
Soluble tumor necrosis factor receptor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period (1997) (15)
The seven pillars of molecular pharmacology: GPCR research honored with Nobel Prize for chemistry. (2012) (14)
Characterization of the B-Raf interactome in mouse hippocampal neuronal cells. (2011) (14)
In-depth analysis of the human CSF proteome using protein prefractionation (2004) (14)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. (2015) (14)
Glucocorticoids inhibit the autoregulatory induction of interleukin-1 in monocytes after endotoxin stimulation. (1996) (14)
BAG-1 diversely affects steroid receptor activity. (2012) (14)
Synergistic Inhibition of the Glucocorticoid Receptor by Radicicol and Benzoquinone Ansamycins (2001) (14)
Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology. (1991) (14)
Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. (2014) (14)
Anxiety and Anxiolytic Drugs (2005) (13)
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response (2017) (13)
Temporal EEG dynamics of non-REM sleep episodes in humans (2000) (13)
Pharmacological Characterisation of Cortical γ-Aminobutyric Acid Type A (GABAA) Receptors in Two Wistar Rat Lines Selectively Bred for High and Low Anxiety-Related Behaviour (2000) (13)
Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditions (2009) (13)
Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate. (2004) (13)
TRH receptor on immune cells:In vitro andin Vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH (1995) (13)
Prolactin but not ACTH increases during sodium lactate-induced panic attacks (2002) (13)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. (2006) (13)
Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating (2015) (13)
Transgenic Mouse Models: New Tools for Psychiatric Research (1997) (12)
Immunology, Signal Transduction, and Behavior in Hypothalamic–Pituitary–Adrenal Axis‐related Genetic Mouse Models (2009) (12)
Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease (2012) (12)
High-Speed imaging reveals opposing effects of chronic stress and antidepressants on neuronal activity propagation through the hippocampal trisynaptic circuit (2015) (12)
In Silico Structural and Functional Characterization of the RSUME Splice Variants (2013) (12)
Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy (2016) (12)
P.1.a.021 Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients (2008) (12)
Die Zukunft der Depressionsforschung (2010) (12)
Relationship between pituitary responses to human corticotropin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls. (1985) (12)
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary—adrenocortical activity in healthy subjects (1997) (11)
Association of GSK 3 Polymorphisms With Brain Structural Changes in Major Depressive Disorder (2009) (11)
Infusions of Tyrosine Hydroxylase Antisense Oligodeoxynucleotide into Substantia Nigra of the Rat: Effects on Tyrosine Hydroxylase mRNA and Protein Content, Striatal Dopamine Release and Behaviour (1997) (11)
The effect of neuroendocrine secretion on brain morphology and EEG sleep in patients with eating disorders (2004) (11)
Sleep and Active Renin Levels – Interaction with Age, Gender, Growth Hormone and Cortisol (2010) (10)
Transrepression of NF-kappaB is not required for glucocorticoid-mediated protection of TNF-alpha-induced apoptosis on fibroblasts. (2000) (10)
P.3.08 Clinical characteristics and treatment outcome in a representative sample of depressed inpatients (2009) (10)
Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent immune response. (1999) (10)
Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment (1988) (10)
Multiaxial Classification of Male Sexual Dysfunction (1985) (10)
Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression. (2008) (10)
INDO calculation of the fulminate–cyanate rearrangement (1970) (10)
Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism (2008) (10)
Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients (2005) (9)
TMEM132D – a putative cell adhesion molecule involved in panic disorder (2011) (9)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression (2009) (9)
A new strategy to analyze possible association structures between dynamic nocturnal hormone activities and sleep alterations in humans. (2009) (9)
Dexamethasone suppression test and weight loss (1984) (9)
Corticotropin-releasing hormone--a new tool to investigate hypothalamic-pituitary-adrenocortical physiology in psychiatric patients. (1986) (9)
Studies of the Hypothalamus-Pituitary-Adrenocortical System: An Example of Progress in Psychoneuroendocrinology (1986) (9)
Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A. (1992) (9)
REM sleep, hippocampus, and memory processing: insights from functional neuroimaging studies. (2013) (8)
AMITRIPTYLINE: LOOKING THROUGH THE THERAPEUTIC WINDOW (1984) (8)
Neuroendocrinology of affective disorder (1995) (8)
Differential Regulation of Interleukin-1 Receptor Antagonist by Proopiomelanocortin Peptides Adrenocorticotropic Hormone and β-Endorphin (1999) (8)
Molecular Understanding of Cytokine–Steroid Hormone Dialogue (2006) (8)
Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder. (1989) (8)
CRHR1-dependent effects on protein expression and posttranslational modification in AtT-20 cells (2008) (8)
Affective temperaments and residual symptoms in patients with mood and anxiety disorders. (2009) (8)
Signaling processes in tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs. (2005) (8)
Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls (2005) (8)
Role of chaperones in signal transduction of the glucocorticoid receptor (2004) (8)
X-Ray photoelectron and Mössbauer spectroscopy of triphenylphosphine–iridium complexes (1973) (8)
Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men (1995) (7)
Sleep Endocrine Effects of Megestrol Acetate in Healthy Men (1998) (7)
Functional Indices of Biological Disturbance (1983) (7)
Effects of 5HT3 Receptor Antagonism by Tropisetron on the Sleep EEG and on Nocturnal Hormone Secretion (1994) (7)
Effects of granulocyte colony-stimulating factor on night sleep in humans. (1999) (7)
Novel dopamine autoreceptor agonists B-HT 920 and DMD 49980 in the treatment of patients with schizophrenia (1992) (7)
[Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness]. (1991) (7)
ACTH and cortisol response to human corticotropin-releasing hormone (h-CRH) in patients after alcohol withdrawal (1989) (7)
Savoxepine: invalidation of an “atypical” neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients (2005) (7)
Effects of weariness of life, suicide ideations and suicide attempt on HPA axis regulation in depression (2021) (7)
Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death. (2012) (7)
Plasma dexamethasone levels in depression: Oral vs. i.v. administration (1987) (7)
Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models (2010) (7)
Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls (2011) (7)
Molecular understanding of cytokine-steroid hormone dialogue: implications for human diseases. (2006) (7)
Role of the hsp70 cochaperone BAG1 in glucocorticoid receptor function and stress-related diseases (2008) (7)
The involvement of neuropeptides in evolution, signaling, behavioral regulation and psychopathology: focus on vasopressin (2005) (7)
Depression and effects of antidepressant drugs on the stress systems (2005) (6)
Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients (2020) (6)
Nocturnal sleep in patients with HIV infection (1990) (6)
Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men. (2019) (6)
Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores (2016) (6)
Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder. (2011) (6)
Dissociation of REM sleep and nocturnal penile tumescence in volunteers treated with brofaremine (1987) (6)
Allopregnanolone acts as an inhibitory modulator on alpha1- and alpha6-containing GABA-A receptors. (1996) (6)
Effects of zidovudine on EEG sleep in HIV-infected men. (1992) (6)
EFFECTS OF THE DOPAMINE AUTORECEPTOR AGONIST ROXINDOLE IN PATIENTS WITH DEPRESSION (1992) (6)
The interplay of variations in the FKBP5 gene and adverse life events in predicting the first onset of depression during a ten-year follow-up (2009) (6)
Die sieben Säulen der molekularen Pharmakologie: GPCR‐Forschung mit Chemie‐Nobelpreis geehrt (2012) (6)
The Binary Corticosteroid Response: Transcriptional Regulation by Mineralo‐ and Glucocorticoid Receptors (1994) (5)
Neurobiologische Forschungskonzepte für die Pharmakotherapie affektiver Störungen (1990) (5)
Altersbedingte Erkrankungen - das Wechselspiel von Veranlagung und Lebensweise (2007) (5)
451. Differential effects of antidepressants on the viability of clonal hippocampal cells (2000) (5)
Cortisol Response to Corticotropin Releasing Hormone in Dexamethasone-Pretreated Patients with Depression (1990) (5)
Identification and characterisation of a gene predisposing to both bipolar and unipolar afective disorders (2004) (5)
Differential enhancement of antidepressant penetration into the brain in mice with Mdr1ab P-glycoprotein gene disruption (2002) (5)
Neurosteroids do not regulate proopiomelanocortin-gene expression in pituitary cells. (2009) (5)
Sleep EEG and nocturnal secretion of cortisol and growth hormone in male normal controls and patients with endogenous depression (1987) (4)
Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder. (2012) (4)
476. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder (2000) (4)
B-HT 920--a novel dopamine autoreceptor agonist in the treatment of patients with schizophrenia. (1990) (4)
Evidence for an enhanced procoagulant state in remitted major depression (2019) (4)
Structural biology: Snapshot of an activated peptide receptor (2012) (4)
The role of clinical research (1995) (4)
104-1 Could a glutathione model integrate both dopamine and glutamate hypothesis of schizophrenia? (1997) (4)
EFFECTS OF CORTICOSTEROIDS AND NEUROSTEROIDS ON SLEEP EEG (1992) (4)
Sleep-wake disturbances in HIV-infected patients - a potential model of the interactions between sleep and the immune system (1996) (4)
Neuroendocrine studies and antidepressant drug development. (1999) (4)
THE CRH‐STIMULATION TEST IN AFFECTIVE AND ANXIETY DISORDER: COMPARISON TO PHYSICAL STRESS (1992) (4)
Biomarkers for the Development of Antidepressant and Anxiolytic Drugs (2008) (4)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach (2014) (4)
[The Munich Vulnerability Study of Affective Disorders. Overview of the results at index study]. (1998) (4)
The anxiolytic effect of the novel CRH1 receptor antagonist R121919 depends on innate emotionality in rats (2000) (4)
Röntgenphotoelektronenspektroskopische Untersuchungen an einigen planaren Pseudohalogeno-d8-Übergangsmetallkomplexen / X-ray Photoelectron Spectra of Some Planar Pseudohalogeno-d8-Transition Metal Complexes (1972) (4)
Transgene Tiermodelle in der psychiatrischen Forschung (1996) (4)
Changes in late auditory evoked potentials induced by corticotropin-releasing hormone and corticotropin fragment 4-9 in male controls. (1996) (4)
Hypothalamic-Pituitary-Adrenocortical Dysfunction in Elderly, Male Marathon Runners: Feedback Sensitivity, Stress Response, and Effects on Verbal Memory (2016) (3)
Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men. (1998) (3)
Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease. (1993) (3)
DBA/2OlaHsd miceinfluence of treatment with the CRHR1-antagonist R121919/NBI 30775 Consequences of chronic social stress on behaviour and vasopressin gene expression in the PVN of (2009) (3)
Special topic section - Psychopharmacogenomics in psychiatry: From serendipity to studies of causality - Introduction (2005) (3)
P.2.a.012 Cordance as a biomarker in sleep-EEG for depression: responders versus nonresponders: a naturalistic study after antidepressant medication (2011) (3)
Effects of transgenic overproduction of CRH on anxiety‐like behaviour (2002) (3)
Dose-dependent effects of endotoxin on human sleep. American Journal of Physiology. (2000) (3)
Reply to “Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression” (2010) (3)
Current theories in the pathophysiology of mood disorders. (1999) (3)
Cordance as a biomarker in sleep-EEG for depression: responders versus non-responders: a naturalistic study after antidepressant medication (2011) (3)
Adrenocortical steroid secretion and 11-beta-steroid hydroxylase activity after pituitary-adrenocortical probes in depression. (1985) (3)
SEROTONIN AND SLEEP REGULATION (1992) (3)
Correction: Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells (2012) (3)
Molekulare Mechanismen der Depressionstherapie (1999) (3)
Unipolar versus bipolar disorder: A distinction not helpful for studies of causality (2005) (3)
Psychoneuroendocrine strategies. (1987) (3)
Neurobiologie der Angst (1993) (3)
Antidepressants do not modulate estrogen receptor α-mediated gene expression (2001) (3)
Acute Stress-Induced Coagulation Activation in Patients With Remitted Major Depression Versus Healthy Controls and the Role of Stress-Specific Coping. (2020) (3)
Long-term antidepressant drug treatment attenuates hypothalamic-pituitary-adrenocortical axis activity in the rat (1995) (3)
Corticotropin-releasing hormone regulates common target genes with divergent functions in corticotrope and neuronal cells (2012) (3)
Association of GSK3 (cid:1) Polymorphisms With Brain Structural Changes in Major Depressive Disorder (2009) (3)
Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression (1995) (3)
Supportive evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and depressive symptoms in affective disorder and schizophrenia (2004) (3)
THE HYPOTHALAMIC‐PITUITARY‐ADRENOCORTICAL (HPA) SYSTEM AND ANTI‐DEPRESSIVE DRUG (AD) ACTION (1992) (3)
Involvement of Vasopressin in Hypothalamic-Pituitary-Adrenal (HPA) System Alterations (1997) (3)
Cortisol promotes non-REM sleep in patients with major depression (2000) (3)
Clinical Application of Antidepressant-Plasma Level Analysis with High Pressure Liquid Chromatography (HPCL) (1986) (3)
Antidepressants do not modulate estrogen receptor alpha-mediated gene expression. (2001) (2)
SNPs in FKBP5 determine a novel subtype of depression characterized by rapid response to antidepressant treatment (2006) (2)
Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients (2007) (2)
Depression and sleep: a comparative study on EEG activity after different antidepressant treatments in mice (2008) (2)
Zukunftsstrategien für die Entdeckung neuer Antidepressiva (2008) (2)
Progesterone-induced changes in sleep in healthy male subjects (1997) (2)
EFFECTS OF PULSATILE APPLICATION OF GROWTH HORMONE‐RELEASING HORMONE (GHRH) AND OF SOMATOSTATIN (SRIF) ON SLEEP EEG AND ON NOCTURNAL RELEASE OF GROWTH HORMONE AND CORTISOL (1992) (2)
Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity (2004) (2)
B-HT 920 and EMD 49980 — novel dopamine autoreceptor agonists in the treatment of schizophrenia (1991) (2)
231. Antisense “knockdown” of CRH1- but not of CRH2-Receptors is anxiolytic in rats (1996) (2)
Erratum: Dynamic DNA methylation programs persistent adverse effects of early-life stress (2010) (2)
Pharmacokinetics of dexamethasone in depressed patients during the dexamethasone suppression test (DST) (1986) (2)
39th Annual European Brain and Behaviour Society Abstracts (2007) (2)
Hormones and brain function (1993) (2)
Signal Pathways Mediating Antidepressant and Antipsychotic Drugs on Neuronal Cell Survival (2004) (2)
Genetics of Endocrine-Behavior Interactions (2002) (2)
The neuropsychopharmacological potential of neurosteroids. (1999) (2)
Neuroendokrinologie und Schlaf (1988) (2)
GR-mediated FKBP5 RNA induction differentially influenced by weight in major depression and healthy controls (2013) (2)
Psychometrische, polysomnographische und neuroendokrine Befunde bei Probanden mit familiärer Belastung für psychiatrische Erkrankungen (1993) (2)
Depression, Anorexia Nervosa and Nutrition: Effects of Starvation on Endocrine Function and Mood (1985) (2)
Planar cell polarity pathway and development of the human visual cortex (2018) (2)
Current scientific programmes in German neurosciences: supported by official sponsors. (2001) (2)
Corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. (1987) (2)
The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety (2012) (2)
Changes in clinical symptoms, sleep EEG and nocturnal hormone secretion during treatment with trimipramine or imipramine — a double-blind comparison in patients with major depression (1993) (2)
The journal of psychiatric research celebrates its 50th anniversary in 2011 (2011) (2)
Corrigendum: New insights into the intracellular distribution pattern of cationic amphiphilic drugs (2017) (2)
Redesigning antidepressant drug discovery (2014) (2)
Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity (2005) (2)
Hypothalamic stress systems in mood disorders. (2021) (2)
Cortisol response to the Dex/CRH test predicts medium-term-outcome in patients with remitted depression (2000) (2)
McMahon et al. reply (2011) (2)
Neuropsychological deficits and long-term outcomes in patients with affective disorders (2004) (2)
312. Magnesium sulphate has GABA-Agonistic effects on sleep in healthy men (1996) (2)
Antidepressant responsiveness in adulthood is permanently impaired after neonatal destruction of the neurogenic pool (2017) (2)
[The future of depression research]. (2010) (2)
Treatment with the CRH1-receptor-antagonist NBI-30775/R121919 improves sleep-EEG in patients with depression (2002) (2)
Changes in late auditory evoked potentials induced by growth hormone-releasing hormone (GHRH) but not somatostatin (SRIF) after peripheral administration in male controls (1995) (2)
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides (2004) (2)
Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response (2007) (2)
Acute neural response to cortisol as detected by functional connectivity analysis (2013) (1)
Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways (2005) (1)
Depression and burnout – Impact on sick leave and job satisfaction. Results from an epidemiological survey (2015) (1)
Polymorphisms in the serotonin receptor 2A gene (HTR2A), parenting styles and the risk of depression in young adulthood: results from a family study (2009) (1)
Is there a genetic continuum between anxiety and depression (2004) (1)
Decreased expression of synaptic proteins in a mouse model of posttraumatic stress disorder (2011) (1)
FC11.06 A Unified Hypothesis of Schizophrenia Based on Glutathione Deficit (2000) (1)
Cannabinoid receptor 1 (CB1) signaling acts as a major regulatory mechanism of hypothalamus–pituitary–adrenal (HPA) axis mediated corticosterone secretion (2006) (1)
High-speed voltage-sensitive dye imaging reveals an enhancing effect of corticotropin-releasing hormone (CRH) on neuronal activity propagation through the hippocampal formation (2009) (1)
Polymorphisms within the 4-aminobutyrate aminotransferase gene are associated with long-latency somatosensory potentials in families vulnerable for affective disorders (2009) (1)
The future of antidepressant pharmacogenetics is arriving. Introduction. (2005) (1)
Glucocorticoids accelerate anti T-cell receptor stimulated growth of rat spleen T-cells (1994) (1)
Molecular genetics of individual differences: What can we learn for related disorders? (2008) (1)
Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways (2009) (1)
488. The role of GHRH in normal and pathological sleep regulation (1996) (1)
Neuroendocrine factors in neurodegenerative and cognitive disorders (1994) (1)
Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (1)
Neuropeptides: Mental Disease (2009) (1)
[The significance of the list of prescribable drugs (so-called positive list) for psychopharmacotherapy]. (2003) (1)
INFLUENCE OF THE PARTIAL BENZODIAZEPINE AGONIST BETAZENIL ON SLEEP‐EEG AND NOCTURNAL SECRETION OF CORTISOL AND GROWTH HORMONE (1992) (1)
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress (2004) (1)
The role of HPA hormones in the neuroregulation of sleep in affective disorders (1991) (1)
Hormones, Stress and Depression (2005) (1)
Conditional overexpression of corticotropin-releasing hormone in mice, an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology (2007) (1)
Implications of obesity and medical illness for major depression - a different endophenotype of major depression in obese patients? (2005) (1)
The Munich vulnerability study on affective disorders: Re-assessment and comparative evaluation of DEX-CRH test results after four years (1998) (1)
Pathophysiology of hypothalamic-pituitary-adrenal axis function in depression (1991) (1)
Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression (2010) (1)
Regarding "The Munich Vulnerability-Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands" Reply (2007) (1)
L.1 Neuroendocrine studies in depression (1996) (1)
Effects of granulocyte colony-stimulating factor on sleep in humans. (1999) (1)
b 2-Adrenergic Receptors Potentiate Glucocorticoid Receptor Transactivation via G Protein bg-Subunits and the Phosphoinositide 3-Kinase Pathway (2001) (1)
Response – Vitamin D: the neglected neurosteroid? (2001) (1)
Evidence for different brain reactivity to external stimuli during phasic and tonic REM sleep: A simultaneous FMRI and EEG study (2003) (1)
Antipsychotic drugs antagonise human serotonin type 3 (5-HT3) receptor currents in a noncompetitive manner (2004) (1)
Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits (2005) (1)
Association of PACAP and PACAPR1 gene variants with unipolar depression and panic disorder (2013) (1)
Antisense targeting of corticotropin-releasing hormone and corticotropin-releasing hormone receptor type I (1996) (1)
Contents Vol. 70, 1999 (1999) (1)
Putative New-Generation Antidepressants (2009) (1)
[ENDOCRINOLOGY and psychiatry]. (1959) (1)
Sleep architecture and sleep continuity in healthy twins (2005) (1)
The combined dexamethasone-suppression/corticotropin-releasing-hormone(CRH) stimulation test, a possible endophenotype for major depression? (2002) (1)
Different brain reactivity during phasic and tonic REM sleep: A simultaneous fMRI and EEG study (2004) (1)
Coordinative mineralocorticoid-like and glucocorticoid-receptor mediated effects of corticosteroids on concanavalin A-induced mitogenesis of rat peripheral blood lymphocytes (1993) (1)
Analysis of cerebrospinal fluid of depressed patients (2004) (1)
P01-82 - Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity (2010) (1)
Effect of acamprosate on the hypothalamic-pituitary-adrenal ( HRA ) system in early abstinent alcoholics (1999) (1)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project (2009) (1)
P-7-9 Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in men (1995) (1)
Altered Hypothalamic-pituitary-adrenocortical Regulation in Individuals at High Familial Risk for Affective Disorders (1996) (1)
P.1.024 The epigenetic machinery of neural cells is modulated by psychoactive drugs (2011) (1)
S.04.04 The genetic basis of individual vulnerability to chronic stress: role of AMPA receptors (2008) (1)
P.1.010 Immunoglobulin G as a potential biomarker for posttraumatic stress disorder (PTSD) (2012) (1)
Psychoneuroendokrinologie der Depression (1985) (1)
Bestandsaufnahme de Forschung in der Neurologie, Psychiatrie und Klinischen Psychologie. Materialien zur Gesundheitsforschung (1994) (1)
Die Entwicklung endokrinologischer Tests in der Depressionsforschung am Beispiel des Dexamethason-Suppressions-Tests (1985) (1)
Schlaf-EEG und nächtliche Sekretion von Kortisol und Wachstumshormon bei Patienten mit endogener Depression und gesunden Probanden (1988) (1)
Psychische Einflüsse auf die Endotoxinwirkung beim Menschen (1996) (1)
Die Münchner Vulnerabilitäts-Studie zu affektiven Erkrankungen Überblick über die Ergebnisse der Index-Untersuchung (1998) (1)
Welche Patienten-Merkmale bestimmen die Erkennensrate des Raucherstatus? Eine Querschnittsstudie bei Hausärzten (2008) (1)
Münchner Vulnerabilitätsstudie: Beitrag von "High-risk"-Studien zur Verlaufsforschung (2003) (1)
Serotoninerge ZNS-Regulation bei affektiven Erkrankungen — Ausgewählte Beispiele aus der Grundlagenforschung (1991) (1)
Therapiewege der Zukunft (2007) (1)
Effekte von Antiglucocorticoiden auf Hormonsekretion und Schlaf (1996) (0)
MIRTAZAPINE PROVOKES PLMS IN YOUNG HEALTHY MEN (2013) (0)
Somatic complaints and somatosensory ERPs as vulnerability markers for affective disorders (2002) (0)
Pathophysiology of the Limbic-Hypothalamic-Pituitary-Adrenocortex System: An Overview (1989) (0)
The impact of genomics on antidepressant drug discovery - From serendipity to hypothesis and back (2002) (0)
Loratadine and analogs: Discovery and preliminary SAR of inhibitors of the amino acid transporter B0AT2 (2014) (0)
Genomic biomarkers for antidepressant treatment outcome (2013) (0)
Acute effects of corticosterone on BOLD signal: a pharmacological fMRI study in rats at 7 Tesla. (2004) (0)
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders (2004) (0)
Dexamethasone Plasma Levels Increase the Sensitivity of GR-Challenge Tests to Detect HPA-Axis Alterations (2014) (0)
Title Estimating the heritability of reporting stressful life eventscaptured by common genetic variants (2013) (0)
Research Activity at the Max Planck Institute for Psychiatry (Munich): Depression in Later Life (1991) (0)
Differential responses in monoaminergic systems in hippocampus and preoptic area after intraperitoneal (IP) administration of lipopolysaccharide (LPS) (1994) (0)
Title Polymorphism in Tmem 132 d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex (2018) (0)
The ABCB 1-Test – Pioneering Personalized Depression Therapy Study Situation (2017) (0)
ABCB1 Genetics and Function Determine Penetrance of Antidepressants Into the Brain: Treatment Implications and Open Research Questions (2014) (0)
EFFECTS OF MINERALOCORTICOID RECEPTOR LIGANDS ON SLEEP EEG AND NOCTURNAL HORMONE SECRETION ‐ STUDIES WITH DEOXYCORTICOSTERONE AND SPIRONOLACTONE (1992) (0)
Prediction of response to antidepressant monotherapy (2004) (0)
Distinct effects of chronic antidepressant treatment on anxiety and depression-related behavior and stress hormone system regulation in an inbred mouse model for affective disorders (2005) (0)
Coupling between the anterior and posterior default mode network midline nodes analyzed during wakefulness and all phases of human non-REM sleep (2009) (0)
O-15-6 Sleep EEG and nocturnal hormone secretion after traumatic brain injury (1996) (0)
Genetic knockout and pharmacological blockade of cannabinoid receptor I affect stress coping behaviours in the mouse forced swim test (2006) (0)
The Dex/CRH-test: A possible endophenotype? (2002) (0)
Neuroendocrine aspects of acute tolerance to ethanol (2002) (0)
The Terror of Trauma | MaxPlanckResearch 3/2011-Focus: Electronics of the future (2011) (0)
Reply (2000) (0)
Neuropeptide S Receptor (NPSR) Gene - Converging Evidence for a Role in Panic Disorder (2020) (0)
Coagulation responses to acute and chronic stress – a comparison between remitted depressed patients and healthy controls (2017) (0)
SLOW WAVE SLEEP INCREASES UNDER PREGNENOLONE IN MAN (1992) (0)
Gender related differential response to dexamethasone in endocrine and immune measures in depressed patients and healthy controls (2011) (0)
Functional validation of P2RX7 as a susceptibility marker for depression using humanized mouse mutants (2009) (0)
From the editors' desks (1996) (0)
Effects of acute and long-term chronic social stress and aging on cognition: involvement of novel synaptic cell adhesion molecules (2009) (0)
Das Neurosteroid Pregnenolon beeinflußt das menschliche Schlaf-EEG wie ein inverser Agonist am GABAΑ-Rezeptor (1996) (0)
S74. Perspective of Personalized Drug Treatment in Depression (2018) (0)
Die Gabe von Dehydroepiandrosteron (DHEA) verlängert den Rapid-Eye-Movement (REM)-Schlaf und erhöht die EEG-Aktivität im Sigma-Frequenzbereich (1996) (0)
Nature or nurture? Revealing the effects of genetic background, sex, and maternal care on isolation-induced ultrasonic calling in mice pups by using a uterine-transfer procedure (2007) (0)
Das Substrat des Denkens (1997) (0)
Functional impact of FKBP51 on cellular pathways (2011) (0)
282. Apoptosis in the rat dentate gyrus: The effect of aging, stimulation by dexamethasone, and the apparent protective role of corticosterone (1996) (0)
An association candidate-gene study on genetic variations within HTR2A in patients suffering from panic disorder (2006) (0)
Zur Eignung des Dexamethasonsuppressionstests als Validierungskriterium operationalisierter Diagnosen endogener Depressionen (1986) (0)
Corticosteroid receptor signaling - Old targets for new drugs (2004) (0)
SNPs in the NTRK2 gene are associated with age-at-onset of depressive disorder and attempted suicide (2007) (0)
Neurobiologische Forschungsstrategien zur Alkoholkrankheit (1991) (0)
Time to bid goodbye. (2019) (0)
S-39-5 Antidepressants and the HPA system (1996) (0)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome (2002) (0)
Effects of pulsatile application of growth hormone-releasing hormone (GHRH) and of somatostatin (SRIF) on nocturnal release of growth hormone (GH) and cortisol and on sleep electroencephalogram (EEG) (1992) (0)
Generation of Conventional and Inducible Cre Mouse Lines Specific for the Adrenal Cortex (2004) (0)
Association of SNP within the serotonin transporter gene with depressive disorder and associated functional parameters (2004) (0)
The Impact of Weight on Differential Alterations of GR-Mediated FKBP5 (2013) (0)
Mice selected for extremes in stress reactivity: modeling clinically relevant endophenotypes of major depression (2009) (0)
Multilevel functional assessment of depressed patients to identify pathophysiologically relevant subgroups (2002) (0)
Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data (2007) (0)
EFFECTS OF THE BENZODIAZEPINE HYPNOTIC TRIAZOLAM ON SLEEP‐EEG AND SLEEP‐ASSOCIATED SECRETION OF CORTISOL AND GROWTH HORMONE (1992) (0)
SPECTROSCOPICAL INVESTIGATION OF METAL COMPLEXES PART 18, X-RAY PHOTOELECTRON AND MOESSBAUER SPECTROSCOPY OF TRIPHENYLPHOSPHINE-IRIDIUM COMPLEXES (1973) (0)
CRH receptor antagonists in mood disorders: Current status (1999) (0)
Thyroid disorders are associated with impaired response to psychopharmacological treatment of major depression (2015) (0)
Reply to — Blood safety (1995) (0)
Neuroendocrine effects of ethanol in sons of alcoholics (2000) (0)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response (2011) (0)
Neurobiologische Vulnerabilitätsmarker für psychiatrische Erkrankungen. Ergebnisse einer Familienstudie bei Angehörigen affektiv erkrankter Patienten. (1996) (0)
Anxiolytic action of atrial natriuretic hormone on panic attacks induced by cholecystokinin tetrapeptide (2001) (0)
Experimental autoimmune encephalomyelitis biomarkers indicate mechanisms mediating neurodegeneration (2007) (0)
Neurobiologische Vulnerabilitätsmarker für psychiatrische Erkrankungen (1996) (0)
Gene-Environment Interaction of the Leptin Receptor (LEPR) Gene and Severe Trauma Moderates Depressive Symptoms and HPA-Axis Function (2009) (0)
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders (2004) (0)
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous FMRI and EEG study (2003) (0)
A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders (2005) (0)
EinfluB des Scbweregrades auf die diagnostiscbe Assoziation von Dexametbason-Nonsuppression und endogener Depression * (1986) (0)
A new model of chronic social stress in mice: long-term neuroendocrine and metabolic changes and behavioural consequences (2005) (0)
Change in HPA system function predicts treatment response in depression (2005) (0)
Neues aus der Schlafforschung. (2001) (0)
Ethanol effects on naloxone-induced stimulation of the hypothalamic-pituitary system in healthy human subjects (2004) (0)
Pharmacogenetics of psychiatric diseases (2004) (0)
Time course of ethanol effects on neuroendocrine function in humans (2004) (0)
The place of peptide systems in major depression and anxiety (2002) (0)
P.3.044 Comparison of flumazenil and lactate in patients with panic disorder (1997) (0)
Epigenetic Modification as Mediator of Gene-Childhood Trauma Interactions (2013) (0)
Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation (2011) (0)
Genetics of stress response and stress-related (2006) (0)
Polymorphisms in the leptin gene are associated with resistance to antidepressant treatment and lower cognitive performance in depression (2007) (0)
Dr. Ströhle and Colleagues Reply (2003) (0)
Influence of the pituitary-adrenocortical system upon the secretion of growth hormone (1989) (0)
CRH, HPA system hyperactivity and depression (2000) (0)
Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study (2010) (0)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? (2005) (0)
High-speed voltage-sensitive dye imaging of neuronal activity propagation through limbic brain networks in vitro (2011) (0)
P-16-3 Growth hormone-releasing peptide stimulates growth hormone, ACTH and cortisol secretion and sleep in man (1996) (0)
Neurobiologische Prädiktoren affektiver Störungen. : Die "Münchner Vulnerabilitätsstudie" im Überblick. (1998) (0)
ALCOHOL DRINKING AND WITHDRAWAL IN MICE LACKING A FUNCTIONAL CRH RECEPTOR 1 (1998) (0)
Infralimbic prefrontal cortex structure affects therapy response dynamics in depressive disorder across clinical diagnostic entities (2007) (0)
Hippocampal functional networking in wakefulness and sleep (2009) (0)
Future Perspectives of Depression Research (2010) (0)
Klinischer Nutzen psychoneuroendokrinologischer Untersuchungen (1986) (0)
Effect of psychosocial stress on FKBP5 and NR3C1 gene expression in healthy young men (2012) (0)
Biological mechanisms underlying the development and maintenance of addictive behaviour (1994) (0)
The P2X7-Receptor – A novel candidate-gene for depression (2005) (0)
GABA transporter1 (GAT1) inhibition mediates distinct emotional and cognitive processes and represents a possible treatment strategy compensating genetic polymorphisms in panic disorder (2005) (0)
Das Neurosteroid Pregnenolon erhöht die "slow wave"- Aktivität im NonREM-Schlaf der Ratte im Gegensatz zu Midazolam (1995) (0)
Definition eines 2. Nadirs im Verlauf der nächtlichen Kortisolsekretion bei depressiven Patienten und gesunden Kontrollpersonen (1988) (0)
Stress-induced gene expression in the paraventricular nucleus of hypothalamus in the mouse strains DBA/2J and C57BL/6J – potential signalling pathways involved (2009) (0)
Clinical application of CRH-tests after dexamethasone pretreatment in depressive patients (1987) (0)
Assessing Behavioural Effects of Chronic HPA Axis Activation Using Conditional CRH-Overexpressing Mice (2011) (0)
Cisplatin inhibits glucocorticoid receptor activation by binding to heat shock protein 90 (2002) (0)
Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders (2004) (0)
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study (2004) (0)
Verändertes Verhältnis von TSH zu ACTH bei depressiven männlichen Patienten. (2000) (0)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression (2009) (0)
Functional neuroanatomical correlates of spectral EEG power during NREM sleep (2005) (0)
PGO-like activity in human REM sleep detected by FMR1 (2005) (0)
SUMOylation and Transcriptional Activity RSUME Enhances Glucocorticoid Receptor (2014) (0)
Transcriptional induction of the rat mineralocorticoid receptor gene by corticosteroids (1995) (0)
Modified antidepressants as innovative tools for identifying novel drug targets (2009) (0)
Generation of a CRH-Cre mouse line to analyze the CRH system (2007) (0)
Proteomic search for intrcellular binding sites of antidepressants (2005) (0)
Stress-regulated genes in the brain of two mouse strains with differential responsiveness to antidepressants (2005) (0)
Can GR function be predicted from the relative cellular amounts of accessory proteins of the GR folding platform (2009) (0)
[CRH antagonists against depression. Viagra for the mind?. Interview by Dr. Stephanie Czajka]. (1999) (0)
Subset of Genetic Markers Associated with Antidepressant Treatment Emergent Suicidal Ideation (2009) (0)
New Approaches Required in Drug Development Process for Antidepressants (2015) (0)
Stress coping and personality traits in acute depression and after improvement (2005) (0)
5-5 The influence of experimental immune-challenges on human sleep (1997) (0)
Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks (2004) (0)
Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes (2004) (0)
Steroid receptor folding and signaling is regulated by the Hsp70 cochaperones BAG-1 M and HspBP1 (2009) (0)
The Hsp90 cochaperone FKBP51 impacts autophagy and protein kinases relevant to psychiatric diseases (2013) (0)
Short-term effects of vasopressin and oxytocin antisense oligonucleotides on the activity of rat neurohypophysial neurons in vivo (1995) (0)
ABCB1 Genotyping Informs the Clinician About Adequacy of Antidepressant Dosing (2014) (0)
Effects of TPR proteins on steroid receptor signaling (2005) (0)
Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice (2016) (0)
HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? (2004) (0)
FKBP5 Critically Impacts Antidepressant Action and Recovery from Chronic Stress (2014) (0)
S.05.05 Future perspectives in CRH research (1997) (0)
Posttraumatic Stress Disorder Subtypes Invalid—Reply (2011) (0)
260. Modulations of the HPA-system by mutagenesis in mice (1998) (0)
RNA Expression Profiling in Age-/Severity-Matched Depressed Inpatients Revealed New Candidates as Possible Biomarkers for Antidepressant Response (2014) (0)
Neuroendocrine studies and antidepressant drug development. Lecture on occasion of the meeting of the Japanese Society of Psychiatry and Neurology. (1999) (0)
Polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor are associated with response to antidepressant drugs (2004) (0)
Other's Effects on Sleep EEG in the Rat Muscimol and Midazolam Do Not Potentiate Each (2015) (0)
P2RX7-a susceptibility gene for mood disorders? (2014) (0)
The history of the association of neuropharmacology and pharmacopsychiatry in german-speaking countries (AGNP) (2004) (0)
Expression of functional active Toll like receptor 4 in normal and adenomatous pituitary cells (2004) (0)
In vivo changes of PRL levels during the T-cell dependent immune response (2002) (0)
Characterisation of DNA methylation marks in stress exposed hippocampal astrocytes (2009) (0)
Stress-induced prolactin secretion is attenuated by ethanol in sons of alcoholic fathers. (2004) (0)
Polymorphisms in metabotropic glutamate receptor 1 are associated with major depressive disorder (2008) (0)
Einfluß von Neuropeptiden auf Schlaf-EEG und nächtliche hormonelle Sekretion (1992) (0)
Synthetic pathways of 3α-reduced neuroactive steroids in major depression and after clinical recovery (1998) (0)
Ethanol dampens stress-induced prolactin secretion only in offspring of alcoholics (2005) (0)
Dissecting the role of Corticotropin-releasing hormone receptor type 1 in Alzheimer's Disease (2011) (0)
P.2.h.025 Working conditions and mental health – results from a longitudinal epidemiological survey (2016) (0)
Polymorphisms in the drug transporter gene ABCB1 in treatment resistant depression: clinical practice (2009) (0)
A genome-wide association study in patients with panic and anxiety disorders (2007) (0)
Mapping effects of sleep deprivation with combined fMRI/EEG (2006) (0)
Neurowissenschaft in ihrer gesellschaftlichen Verantwortung (1997) (0)
Proton-MR-spectroscopy (1 H-MRS) of the left hippocampus and anterior cingulate cortex in recurrent unipolar depression: results from 176 subjects (2009) (0)
Heterozygosity of P2RX7 with depression-associated risk allele alters sleep architecture (2012) (0)
A 50 kb LD block in the CLEC16A gene is highly associated with multiple sclerosis in a German population (2014) (0)
Role of Testosterone in Male Sexual Impotent Patients (1985) (0)
IGF-1 is elevated in patients with depression and non-remitters to antidepressant treatment (2013) (0)
Kombinierter Corticotropin-Releasing-Hormone-Dexamethasonsuppressionstest bei Patienten mit endogener Depression (1988) (0)
P.3.10 Glutamate and interleukin receptor genes are associated with antidepressant treatment emergent suicidal ideation (2008) (0)
Endocannabinoid signaling modulates HPA axis activity in the mouse - implications for depression disorders (2007) (0)
P-8-7 Sleep endocrine effects of neuropeptide Y in men reveal a GABAA-agonistic action (1996) (0)
289. Effects of cortisol on sleep EEG and growth hormone secretion in major depression depending on HPA-function? (2000) (0)
Differences in intrinsic amygdalar network features between animals of the high- vs. low-anxiety-related behavior (HAB, LAB) mouse model (2011) (0)
43-4 Psychopharmacological properties of brain-derived cytochrome P450-dependent neuroactive steroids (1997) (0)
Impact of lipid raft integrity on GABAA receptor function and its modulation by benzodiazepines (2011) (0)
BAG-1 as a candidate for causing corticosteroid receptor resistance: A functional domain analysis (2002) (0)
Towards a new animal model for stress related disorders (2005) (0)
Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients (2009) (0)
Sleep-Endocrine Effects of Growth Hormone-Releasing Hormone (GHRH) in Major Depression (1994) (0)
Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment (2007) (0)
DETERMINANTS OF MATERNAL AND INFANTICIDAL BEHAVIOR IN FEMALE MOUSE F1 HYBRIDS (2007) (0)
The Munich PTSD Biomarker Study (MPBS) (2009) (0)
Recurrent Depression is Associated with Earlier Ocurrence of Metabolic Syndrome and Aggravates the Effect of Vascular Risk Factors on Cerebral Microangiopathy Determined By MRI (2013) (0)
Glucocorticoid Induced FKBP5-gene Expression as a Biomarker for Depression? (2011) (0)
Combined fMRI/EEG to map non-genomic effects of exogeneous cortisol (2011) (0)
Automatic detection of rapid-eye movements in REM sleep (2011) (0)
Analysis of Urocortin 2 overexpressing mice (2005) (0)
The development of endocrinological tests for research in depression as illustrated by the dexamethasone suppression test (1986) (0)
[Detlev Ploog (1920 through 2005)]. (2006) (0)
The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis (2004) (0)
Resting state network alterations in major Depression (2011) (0)
Optimizing antidepressant treatment dosage based on ABCB1 gene variants – Results from a randomized clinical study (2015) (0)
Endokrinologische Typisierang depressiver Patienten durch den Dexamethason-Suppressionstest (1984) (0)
Association of the Adrenergic Receptor Alpha l B with Antidepressant Treatment in the MARS Study (2009) (0)
Chronic application of a CRH receptor type 1 antagonist decreases rapid-eye movement sleep in a mouse model of brain-specific CRH excess (2012) (0)
The hsp70 cochaperones BAG-1 M and HspBP1 as possible cause for glucocorticoid resistance (2007) (0)
A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation (2004) (0)
Genome-wide association study of antidepressant induced treatment emergent suicidal ideation (TESI) (2009) (0)
Associations between thyroid hormone transporter gene variants and grey matter volume changes (2011) (0)
Towards brain-specific functions of histone deacetylases (HDACs) using genetic mouse models (2011) (0)
Cerebrospinal fluid levels of the soluble amyloid precursor protein in patients with mild cognitive impairment and different forms of dementia: a diagnostic marker (2002) (0)
The cortisol and ACTH response in the combined Dex/CRH test of acutely depressed patients varies significantly between 5-HT2A receptor genotypes (2005) (0)
Vasoaktives Intestinales Peptid (VIP) führt zu einer Vorverlagerung des REM-Schlafes und der Kortisolsekretion beim Menschen (1996) (0)
A new model of chronic social stress in mice: long-term neuroendocrine and behavioural consequences (2005) (0)
205. Corticosteroid receptors in psychiatric disease: Implications for pathophysiology and treatment (1998) (0)
Subregional amygdala functional connectivity: normative maps and influence of oral citalopram in healthy volunteers (2009) (0)
The Role of FKBP51 in the regulation of the glucocorticoid receptor (2005) (0)
The non-synonymous P2RX7 SNP rs2230912 is associated with affective disorders: Results from an association study in major depression and from a meta-analysis (2011) (0)
Einfluß des Corticotropin-Releasing-Hormone auf schlafassoziierte neurophysiologische Parameter: Eine breitbandspektralanalytische Untersuchung des Ganznachtschlaf-EEGs (1988) (0)
S.07.08 Brain networks in sleep as revealed by combined EEG and fMRI (2004) (0)
Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene (2005) (0)
Effect of mirtazapine on glucose metabolism and resting energy expenditure: Observations in “super-healthy” men under highly standardized conditions (2019) (0)
Recurrent suicide attempts affect normalization of HPA axis dysregulation after recovery from major depression (2022) (0)
Major depressive disorder: Identifying phenotypic subtypes for genetic studies. (2005) (0)
Vasoaktives Intestinales Peptid (VIP) verlangsamt Non-REM/REM-Zyklen und moduliert die nachtliche Hormonsekretion des Menschen (1996) (0)
Genetically modified animals to analyse the abnormalities in the hypothalamic-pituitary-adrenal axis in depression (2001) (0)
Polysomnographic, neuroendocrine and psychometric risk factors for depression (2002) (0)
P.1.a.021 Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls (2011) (0)
209. CRF-receptors as drug targets for treatment of anxiety and depression (2000) (0)
P.2.b.011 Relationship of variations in the leptin receptor (LEPR) gene and depressive symptoms is moderated by severe trauma (2008) (0)
S.04.1 Analysis of cerebrospinal fluid of depressed patients (2003) (0)
P.2.b.010 Genetic predictor of antidepressant response for major depressive disorder: a genome-wide association study and pathway analysis (2013) (0)
Unterschiedlicher Einfluss von Trimipramin und Imipramin auf das Schlaf-EEG und die nächtliche Hormonsekretion während antidepressiver Behandlung. (1997) (0)
P.3.04 Brain networks in sleep as revealed by combined EEG and fMRI (2004) (0)
Effect of long-term intracerebroventricular (ICV) infusion of corticotropin releasing hormone on endocrine and immune function in the rat (1994) (0)
P.2.036 Effects of acute lorazepam on functional connectivity and electroencephalography: a pharmacological fMRI/EEG study (2010) (0)
S.12.01 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
The effects of neuroactive steroids upon sleep in humans and rats (1996) (0)
Genetic Variants in the ABCB1 Gene Determine Bioavailability of Antidepressants in the Brain (2017) (0)
P.1.011 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
S04.01 - Genetic determinants of neurobiological vulnerability markers in depression (2008) (0)
O-25-3 The combined dexamethasone/CRH-test in rats: Characterization of the HPA axis activity in aging (1996) (0)
Untitled (2015) (0)
P.1.043 Toxicity of antidepressant drugs: A comparative in vitro study (1996) (0)
P.1.26 Identification of stress-regulated genes in the brain of two mouse strains that differ in the antidepressant responsiveness (2005) (0)
Neuroendocrine regulation in mice deficient for the corticotropin-releasing hormone receptor 1 (CRHR1): activation of the vasopressinergic system and involvement of CRHR1 in adrenocortical function (2000) (0)
P.1.g.014 The role of the dopamine beta-hydroxylase (DBH) gene in human cognitive function (2008) (0)
P.4.012 Behavioural and molecular alterations in FKBP52+/− mice under basal and chronic stress conditions (2012) (0)
Development of a genetic classifier that predicts dysregulated stress responses in depressed patients to enable precision psychiatry (2022) (0)
P.2.a.007 Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression (2008) (0)
Corrigendum to “Regulation of the developing hypothalamic–pituitary–adrenal axis in corticotropin releasing hormone receptor 1-deficient mice” [Neuroscience 119 (2003) 589–595]☆ (2005) (0)
Für eine bessere Depressionstherapie - eine Vision (2011) (0)
Schlaf und Immunsystem. Schlafmodulation durch Zytokine (1997) (0)
P.4.c.003 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
Perspective of personalised drug treatment in depression (2018) (0)
P.2.a.003 Stress coping strategies and HPA axis regulation predict relapse risk in remitted depression (2011) (0)
Psychotropic Effect of Combined Estrogen-Vit B6 Treatment in Endogenously Depressed Females (1985) (0)
Possible genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders (2006) (0)
Transgenic mouse models as tools for understanding central CRH signalling (2008) (0)
245. Repetitive transcranial magnetic stimulation—evidence for antidepressant-like and neuroprotective effects (2000) (0)
P.3.028 Somatisation in major depression, genetic association and clinical features (2010) (0)
P.1.e.016 Dexamethasone plasma levels impact glucocorticoid receptors-challenge tests for detection of HPA-axis alterations (2015) (0)
S77. Genetic Variants in the ABCB1-Gene Determine Bioavailability of Antidepressants in the Brain (2018) (0)
Disruption of feeding behaviour in corticotropin releasing hormone type-1 receptor (CRHR1) deficient mice is dependent on glucocorticoids (2000) (0)
GR/MR imbalances in depression and anxiety (2006) (0)
P.2.h.001 Polymorphisms in the BDNF gene are associated with antidepressant treatment response (2010) (0)
The effects of RS-86 on sleep with respect to depression and HLA-type (2002) (0)
P.3.01 High weight affects treatment response in major depression (2007) (0)
Major depressive disorder: Genetic association analyses using subphenotypes (2006) (0)
Beyond noise: reply to Laufs et al. (2007) (0)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors (2009) (0)
Stress in the life of a neuron (2008) (0)
P.2.09 Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress (2004) (0)
P.4.013 Assessing CRH-mediated anxiogenic and anxiolytic effects using region-and neurotransmitter-specific CRH overexpressing mice (2012) (0)
Antidepressive und antipanische Effekte von Roxindol (1996) (0)
Die psychopharmakologische Bedeutung von Neurosteroiden (1996) (0)
Urinary Multisteroid Analysis Applying Glass-capillary Gas-chromatography - A New Technique to Assess Adrenocortical Activity in Depression (1986) (0)
Neuroendocrine Dysfunctions in Affective Disorders: Effects of Clinical Changes (1989) (0)
264. Sleep-endocrine effects of GHRH in depression are sexually dimorphic (2000) (0)
Wirkung von Antidepressiva auf Schlaf-EEG, Penisplethysmographie und nächtliche hormonelle Sekretion von Patienten mit endogener Depression und gesunden Probanden (1988) (0)
Untersuchung über den Einfluß von Nordiazepam auf die Plasmakonzentration von Amitriptylin und Nortriptylin (1986) (0)
Röntgenphotoelektronenspektroskopische Untersuchungen an Bis(triphenylphosphin)-Platin(II)-(Pseudo-)halogeniden / X-Ray Photoelectron Spectra of Bis(triphenylphosphine)-platinum(II) (pseudo)halides (1973) (0)
Reply (2007) (0)
Das endokrine Psychosyndrom (1997) (0)
Vergleichende Untersuchungen über die Effekte von Midazolam, Flumazenil und Bretazenil auf das Schlaf-EEG und die schlafassoziierte Sekretion von Kortisol und Wachstumshormon gesunder Probanden (1992) (0)
Transrepression of NF- U B is not required for glucocorticoid-mediated protection of TNF- K -induced apoptosis on ¢broblasts (2000) (0)
Laktatprovokation bei Angst und Depression (1988) (0)
Wirkmechanismen der Antidepressiva. (1998) (0)
Der Einfluss experimenteller Stimulation der primären Wirtsantwort auf den Schlaf des Menschen (1996) (0)
SNPs in the NTRK2 gene are associated with depressive disorder (2007) (0)
Neurobiologische Grundlagen der „Spezifität“ verschiedener Antidepressiva (1991) (0)
Untersuchungen zur Glucosetoleranz bei Patienten mit einer Major Depression im Vergleich zu gesunden Kontrollpersonen (2009) (0)
Neuroendokrinologische Modellvorstellungen bei depressiven Erkrankungen (1988) (0)
Was bedeutet die Vorschlagsliste verordnungsfähiger Arzneimittel (sog.Positivliste) für die Psychopharmakotherapie? (2003) (0)
Untersuchungen zur Pharmakokinetik von Dexamethason bei Patienten mit Depression während des Dexamethasonsuppressionstests (DST) (1988) (0)
Nervenheilkunde als angewandte Neurowissenschaft (1996) (0)
Do data from a large prospective naturalistic study (N=1014, MDD) support the new FDA recommendation concerning antidepressants suicidality risk? (2007) (0)
Assoziation zwischen Herzerkrankungen und Depressionen (2007) (0)
Molekulare Mechanismen der Glukokortikoidtherapie (1999) (0)
[Interview with professor Florian Holsboer (interview by Angelika Staub)]. (2009) (0)
Vorschlagsliste verordnungsfähiger Arzneimittel (sog. Positivliste) Was bedeutet dies für die Psychopharmakotherapie (2003) (0)
ENDOTOXIN‐ AND CORTICOTROPIN‐RELEASING HORMONE (CRH) ‐ INDUCED RELEASE OF ACTH AND CORTISOL: A COMPARATIVE STUDY IN HUMAN MALES (1992) (0)
Psychopathological, cognitive and neuroendocrine responses to treatment with amitriptyline in elderly depressed patients (1991) (0)
Dysregulation von REM- und Tiefschlaf als Vulnerabilitätsmarker bei Erstgradangehörigen affektiv erkrankter Patienten (1993) (0)
Der Einfluss des Hepatitis B Virus X-assoziierten Protein 2 (XAP2) auf die Funktion des Glukokortikoidrezeptors (2008) (0)
27th Annual Meeting of the Swiss Society of Biological Psychiatry (2007) (0)
Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels (2007) (0)
List of Contributors, Part 2 (2005) (0)
VKučinskas-2001-2016 (2016) (0)
Dissecting CRHR1-mediated pathways via microarray technology (2007) (0)
Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder (2004) (0)
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants (2004) (0)
Genetic predictor of antidepressant response for major depressive disorder accounting for clinical subgroups: A genome-wide association study (2014) (0)
Disease-oriented Genome Networks Diseases of the Nervous System Network : Systematic Gene Identification and Functional Analyses in Common CNS Disorders Project : Identification of Novel Candidate Genes in Unipolar Depression (2005) (0)
Deletion of FKBP5 alters stress-related parameters in mice (2009) (0)
Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders (2004) (0)
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety (2004) (0)
Mechanistic aspects of cell type and drug specific inhibition of DNA methyltransferase 1 (2011) (0)
Circadian time structure of septic shock - timing is everything - reply (1997) (0)
P456 Magnesium sulphate has GABA-agonistic effects on sleep in healthy men (1996) (0)
Individual susceptibility to chronic stress is modulated by AMPA receptor function (2008) (0)
The youth hormone DHEA: A benefit for pathologic sleep alterations? (2004) (0)
Detlev Ploog (1920 bis 2005) (2006) (0)
Altered sleep-endocrine regulation in depression — effect of GHRH (1999) (0)
Genome-Wide Association Study of Body Weight in Patients with Major Depression (2010) (0)
Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls (2011) (0)
S-16-1 Neuropeptides in human sleep regulation (1996) (0)
Penetration of antidepressant drug into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1ab P-glycoprotein disruption (2000) (0)
Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder (2006) (0)
Corticotropin releasing hormone (CRH): a new tool for studying pituitary-adrenocortical dysfunction in depression (1986) (0)
Modern Psychiatry : From Genes to Therapies ' Modern Psychiatry : From Genes to Therapies ( (2010) (0)
Subject Index Vol. 70, 1999 (1999) (0)
Limbic NF-KB signalling controls stress-induced anxiety and antidepressant effects independently of the HPA axis (2010) (0)
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain (2004) (0)
Severe trauma moderates the relationship between variations in the vasopressin receptor 1A gene (AVPR1A) and depression in a family-based association lest (2008) (0)
Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder (2018) (0)
MRI used as tool to quantify white matter pathology and its interaction with vascular risk factors in depression (2013) (0)
Plasma dexamethasone kinetics during the dexamethasone suppression test after oral and intravenous administration of the test drug to patients with depression (1987) (0)
Reply (1999) (0)
Expressing emotions: Avp and Crh are involved in the phenotype of mice bred for extremes in anxiety-related behavior (2007) (0)
22. Symposium of the AGNP, Nuremberg, September 26th to 29th, 2001. Editorial. (2001) (0)
CENTRAL CORTICOTROPIN-RELEASING HORMONE OVEREXPRESSION ENHANCES REM SLEEP IN CONDITIONAL TRANSGENIC MICE (2009) (0)
Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism (2005) (0)
Vorkommen und Funktion des toll-like Rezeptor 2 in follikulostellaren Hypophysenzellen (2012) (0)
The neuropeptide galanin increases rem latency and alleviates depressed mood in patients with depression (2003) (0)
Neddylation, a new post-translational modification, controls dendrite and synapse development (2012) (0)
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men. (2023) (0)
Sleep and hormones (1991) (0)
Polymorphisms of the dopamine beta-hydroxylase (DBH) gene show associations with cognitive flexibility in mentally healthy adults (2009) (0)
Cortisol levels and gene expression changes in posttraumatic stress disorder: the role of endophenotypes in determining common biological pathways in psychiatric disorders (2010) (0)
Cytokines enhance target cell sensitivity to glucocorticoids (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Florian Holsboer?

Florian Holsboer is affiliated with the following schools: